Memory loss

MEMLOSS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R41.1, R41.2, R41.3 Cause of death: ICD-10 — R41.1, R41.2, R41.3 2 out of 7 registries used, show all original rules.	3480
4. Check minimum number of events None	3480
5. Include endpoints None	3480
6. Filter based on genotype QC (FinnGen only)	3480

Control definitions (FinnGen only)

Control exclude: F5_DEMENTIA, G6_ALZHEIMER, G6_AD_WIDE

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	MEMLOSS
CONTROL_EXCLUDE	F5_DEMENTIA\|G6_ALZHEIMER\|G6_AD_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R41[1-3]
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R41[1-3]
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Memory loss based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	26901	15057	11756
Only index persons	25069	14240	10829
Unadjusted period prevalence (%)
Whole population	0.39	0.43	0.33
Only index persons	0.48	0.52	0.41
Median age at first event (years)
Whole population	71.05	72.62	69.03
Only index persons	70.85	72.43	68.77

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3480	1835	1645
Unadjusted period prevalence (%)	0.67	0.63	0.73
Median age at first event (years)	68.75	67.79	69.81

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3124: Matched controls
31241

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N06DA02

ATC

donepezil; oral

110.1

323.0

484

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

16.4

323.0

1229

1191

R41.3

ICD-10 Finland

Other amnesia

8216.3

323.0

2984

115

N06DX01

ATC

memantine; oral

136.9

323.0

553

G30.1

ICD-10 Finland

Alzheimer disease with late onset

94.8

323.0

618

N06DA03

ATC

rivastigmine; oral, transdermal

122.4

297.7

319

XA800

NOMESCO Finland

Neuropsychological investigation

15.5

275.0

471

353

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

+∞

267.6

253

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

3.8

224.2

1243

4599

F03

ICD-10 Finland

Unspecified dementia

26.4

207.5

293

122

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

272.6

201.5

204

R4110

NOMESCO Finland

Physiotherapy

3.1

171.1

1269

5589

P20

ICPC

Memory disturbance

4.2

165.1

737

2156

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

24.5

150.7

217

G45.4

ICD-10 Finland

Transient global amnesia

9.8

144.8

307

344

Z01.9

ICD-10 Finland

Special examination, unspecified

6.0

144.4

431

808

F06.7

ICD-10 Finland

Mild cognitive disorder

9.6

120.2

256

287

R41.2

ICD-10 Finland

Retrograde amnesia

409.4

119.5

119

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

4.4

118.9

481

1247

N05AX08

ATC

risperidone; systemic

5.5

118.4

376

752

N06AX11

ATC

mirtazapine; oral

2.6

118.3

1232

6319

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

52.2

116.3

140

G30

ICD-10 Finland

Alzheimer disease

155.9

114.0

120

N05AH04

ATC

quetiapine; oral

3.4

104.9

590

2012

AA1AD

NOMESCO Finland

CT of head and brain

2.5

102.3

1068

5381

N06DA04

ATC

galantamine; oral

114.0

101.6

110

R53

ICD-10 Finland

Malaise and fatigue

2.7

99.7

877

4005

TAB00

NOMESCO Finland

Lumbar puncture

6.9

98.6

261

410

A28

ICPC

Limited function/disability NOS

2.6

90.2

778

3480

XF400

NOMESCO Finland

ECG with 12 standard connections

2.6

88.9

793

3615

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.7

88.4

735

3213

G30.8

ICD-10 Finland

Other Alzheimer disease

45.2

85.1

105

Z71.8

ICD-10 Finland

Other specified counselling

2.4

83.2

881

4379

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.9

80.8

576

2277

SPAT1053

SPAT

Memory test

2.6

80.6

733

3351

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.8

80.1

374

1083

R42

ICD-10 Finland

Dizziness and giddiness

2.3

79.1

928

4831

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.2

73.5

429

1475

WX002

NOMESCO Finland

Sedation and analgesia

2.3

72.3

834

4273

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.9

68.9

306

844

N03AG01

ATC

valproic acid; systemic, rectal

4.4

67.0

259

628

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.9

66.3

466

1808

Z01.7

ICD-10 Finland

Laboratory examination

2.8

66.1

492

1977

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

105.3

66.1

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

3.0

66.0

418

1514

ZXA05

NOMESCO Finland

Left side

2.0

63.3

1039

6144

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.9

62.2

417

1566

N06AB10

ATC

escitalopram; oral

2.4

61.5

592

2739

G30.0

ICD-10 Finland

Alzheimer disease with early onset

214.2

61.3

N06AB04

ATC

citalopram; systemic

2.2

59.2

754

3985

ZXA00

NOMESCO Finland

Right side

2.0

58.7

1075

6592

U13

ICPC

Bladder symptom/complaint other

4.7

57.1

204

456

R41.1

ICD-10 Finland

Anterograde amnesia

+∞

55.4

XCK10

NOMESCO Finland

Photography of fundus of eye

2.5

54.8

475

2066

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

54.4

925

5476

R41.0

ICD-10 Finland

Disorientation, unspecified

4.9

51.0

175

374

F01.2

ICD-10 Finland

Subcortical vascular dementia

109.9

49.9

R51.80

ICD-10 Finland

Headache

2.4

49.2

484

2240

N05AH03

ATC

olanzapine; systemic

4.0

48.0

205

543

M79.6

ICD-10 Finland

Pain in limb

1.8

47.5

1153

7659

KMAK

NOMESCO Finland

1.7

47.4

1418

10062

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.6

47.1

226

661

R4120

NOMESCO Finland

Occupational therapy

3.1

47.0

274

929

S06.0

ICD-10 Finland

Concussion

2.6

46.9

383

1603

G40.9

ICD-10 Finland

Epilepsy, unspecified

4.7

46.5

166

370

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.6

46.0

380

1599

WX892

NOMESCO Finland

Monitored bed care

2.6

44.8

348

1414

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

44.5

1048

6856

N06AX16

ATC

venlafaxine; oral

2.5

44.5

399

1756

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

42.8

951

6089

M25.5

ICD-10 Finland

Pain in joint

1.9

42.3

844

5204

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

93.4

41.9

A98

ICPC

Health maint/preventive medicine

2.2

41.7

2854

25755

F01.9

ICD-10 Finland

Vascular dementia, unspecified

22.6

41.4

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

41.2

745

4431

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

4.8

41.2

143

310

P70

ICPC

Dementia

11.8

40.7

N03AF02

ATC

oxcarbazepine; oral

4.5

39.5

147

342

N03AX09

ATC

lamotrigine; oral

4.2

38.7

152

373

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

16.8

38.1

R55

ICD-10 Finland

Syncope and collapse

2.2

38.0

442

2195

WX110

SPAT

3.7

38.0

172

479

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.4

37.3

193

598

N05BA01

ATC

diazepam; systemic, rectal

2.1

36.9

476

2473

WX110

NOMESCO Finland

Local anesthesy

1.6

36.8

1904

15296

N06AX21

ATC

duloxetine; oral

2.4

36.3

342

1537

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.4

36.1

333

1480

N06AB06

ATC

sertraline; oral

2.5

35.5

304

1299

SPAT1256

SPAT

Intramuscular and subcutaneous injection

0.6

35.2

681

10118

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

34.1

846

5524

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.6

33.9

162

472

R5110

SPAT

4.0

33.2

139

362

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.8

33.0

224

837

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

32.4

419

2170

K02.1

ICD-10 Finland

Caries of dentine

1.6

32.3

1427

10853

EB1AA

SPAT

3.2

32.1

174

558

M54

ICD-10 Finland

Dorsalgia

2.2

32.1

354

1711

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

31.8

1832

14835

Z73.6

ICD-10 Finland

Limitation of activities due to disability

7.8

31.7

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

+∞

31.3

N30

ICD-10 Finland

Cystitis

2.5

31.2

267

1139

F05.9

ICD-10 Finland

Delirium, unspecified

5.0

30.9

102

210

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.0

30.8

434

2325

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.9

30.5

544

3177

M54.5

ICD-10 Finland

Low back pain

1.6

30.3

926

6372

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

30.3

1176

8617

XF606

NOMESCO Finland

Ortostatic test

8.7

29.9

A11

ICPC

Chest pain NOS

2.2

29.2

306

1442

N06AX26

ATC

vortioxetine; oral

3.2

29.2

158

507

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.7

29.1

132

369

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4.8

28.9

208

SPAT1249

SPAT

Treatment-related counselling outside office

0.6

28.9

605

8920

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

28.8

550

3282

N30.0

ICD-10 Finland

Acute cystitis

1.9

28.7

472

2673

K59.0

ICD-10 Finland

Constipation

2.5

28.7

232

957

Z02.7

ICD-10 Finland

Issue of medical certificate

2.6

28.7

224

909

F32

ICD-10 Finland

Depressive episode

3.2

28.5

154

493

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.5

28.4

237

997

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.3

28.3

283

1304

N03AX16

ATC

pregabalin; oral

1.7

28.2

759

5026

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

28.0

302

1439

N05BA04

ATC

oxazepam; oral

1.7

27.9

732

4813

H81

ICPC

Excessive ear wax

1.8

27.9

604

3752

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

27.8

481

2774

SPAT1153

SPAT

Removal of sutures

0.6

27.7

502

7679

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.3

27.7

266

1203

N17

ICPC

Vertigo/dizziness

2.0

27.5

409

2231

N02BE01

ATC

paracetamol; systemic, rectal

1.7

27.5

2589

23189

G31.0

ICD-10 Finland

Circumscribed brain atrophy

21.3

27.4

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

5.9

27.3

136

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.7

27.2

624

3940

-1

NOMESCO Finland

1.6

27.2

852

5871

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.4

26.4

230

986

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.5

26.3

217

905

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

26.3

1235

9374

W19

ICD-10 Finland

Unspecified fall

2.1

25.8

312

1565

F05.1

ICD-10 Finland

Delirium superimposed on dementia

40.4

25.8

F00

ICD-10 Finland

Dementia in Alzheimer disease

73.3

25.8

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.8

25.8

173

641

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

25.7

1430

11248

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.0

25.4

346

1823

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

25.4

976

7056

C10AA05

ATC

atorvastatin; oral

1.5

25.4

1292

9959

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.4

24.8

228

1007

SPAT1325

SPAT

Vaccination

0.6

24.7

624

8898

R4130

NOMESCO Finland

Speech therapy

3.9

24.7

103

269

J01DB01

ATC

cefalexin; oral

1.5

24.5

2349

20688

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

24.2

632

4125

SPAT1312

SPAT

General health counselling

0.6

24.1

451

6884

N05CF01

ATC

zopiclone; oral

1.5

24.1

1045

7744

F34.1

ICD-10 Finland

Dysthymia

3.5

24.1

115

336

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

24.0

741

5057

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.6

24.0

178

701

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.6

24.0

182

727

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

4.5

23.6

193

N06AB03

ATC

fluoxetine; oral

1.9

23.6

361

1984

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.5

23.5

185

754

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

0.6

23.2

436

6659

C10AA01

ATC

simvastatin; oral

1.5

23.1

1518

12264

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

7.8

23.0

N05CF02

ATC

zolpidem; oral

1.7

23.0

494

3044

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

22.7

518

3250

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

120.9

22.6

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

22.4

561

3610

M02AA07

ATC

piroxicam; topical

1.5

22.3

1153

8843

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

8.0

22.2

R35

ICD-10 Finland

Polyuria

2.2

22.2

236

1118

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.8

21.9

247

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

21.8

461

2824

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

21.7

575

3757

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

80.7

21.7

A02BC05

ATC

esomeprazole; systemic

1.5

21.5

1182

9159

ZXA10

NOMESCO Finland

Bilateral

1.6

21.5

636

4279

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.2

21.4

233

1111

WYA30

SPAT

11.2

21.4

A06AD11

ATC

lactulose; oral

1.7

21.3

504

3187

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

17.5

21.3

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

21.1

917

6756

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

21.0

1323

10519

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.5

20.9

288

J01FA06

ATC

roxithromycin; oral

1.5

20.9

1147

8866

N05CD07

ATC

temazepam; oral

1.7

20.9

456

2812

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

16.7

20.9

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

20.9

1378

11056

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

20.8

333

1858

Z71.9

ICD-10 Finland

Counselling, unspecified

2.3

20.6

190

841

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

0.6

20.4

468

6868

N05AX12

ATC

aripiprazole; systemic

4.0

20.4

208

F51.0

ICD-10 Finland

Nonorganic insomnia

1.9

20.2

321

1784

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

20.2

1275

10119

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

20.1

1014

7689

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.8

20.1

131

477

WX320

NOMESCO Finland

Spinalanesthesy

1.5

19.9

713

5014

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.9

19.9

121

422

UJH02

NOMESCO Finland

Anoscopy

2.6

19.9

150

597

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

8.5

19.9

N03AX14

ATC

levetiracetam; systemic

3.5

19.7

265

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.7

19.7

506

3272

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

2.1

19.6

221

1075

A04

ICPC

Weakness/tiredness general

1.7

19.6

410

2497

G44.2

ICD-10 Finland

Tension-type headache

1.8

19.6

344

1980

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.4

19.5

171

737

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

19.4

924

6915

ZXC20

NOMESCO Finland

Use of chemical agents

3.1

19.4

106

345

N03AF01

ATC

carbamazepine; oral, rectal

2.3

19.4

180

801

R05

ICD-10 Finland

Cough

1.6

19.2

564

3774

N03AX12

ATC

gabapentin; oral

1.7

19.1

457

2892

XF404

NOMESCO Finland

Ambulatory ECG

1.8

19.1

323

1835

N06AX03

ATC

mianserin; oral

2.4

19.1

170

740

RS222

NOMESCO Finland

4.7

19.0

141

D11

ICPC

Diarrhoea

1.9

19.0

277

1492

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

19.0

461

2930

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

2.7

18.9

129

484

WX212

NOMESCO Finland

Femoral plexus blockade

3.5

18.9

269

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

5.1

18.8

117

N05BA06

ATC

lorazepam; systemic, sublingual

2.4

18.8

167

726

U72

ICPC

Urethritis

3.3

18.7

288

R83

ICPC

Respiratory infection other

1.7

18.6

453

2881

J01MA02

ATC

ciprofloxacin; systemic

1.4

18.5

1165

9190

I25

ICD-10 Finland

Chronic ischaemic heart disease

2.2

18.5

201

959

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

0.6

18.4

309

4879

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

18.2

228

1154

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

18.2

310

1764

S18

ICPC

Laceration/cut

1.4

18.2

1269

10196

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

18.2

551

3712

L17

ICPC

Foot/toe symptom/complaint

1.5

18.2

745

5384

R01AD09

ATC

mometasone; nasal

1.4

18.1

1083

8452

M01AB05

ATC

diclofenac; systemic, rectal

1.4

18.1

1793

15333

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

6.1

18.0

S01.0

ICD-10 Finland

Open wound of scalp

2.0

18.0

229

1172

G04CA02

ATC

tamsulosin; oral

1.5

17.9

741

5366

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

17.9

1056

8217

A02BC02

ATC

pantoprazole; systemic

1.4

17.9

1902

16453

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

3.0

17.8

104

354

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

16.6

17.8

T90.5

ICD-10 Finland

Sequelae of intracranial injury

5.5

17.8

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

17.7

652

4595

F0019, G301

ICD-10 Finland

+∞

17.7

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

17.7

1548

12925

VALMI

NOMESCO Finland

1.6

17.7

575

3939

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.4

17.6

157

683

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

36.9

17.6

R06.0

ICD-10 Finland

Dyspnoea

1.5

17.6

791

5827

EBA30

NOMESCO Finland

Excision of root of tooth

2.2

17.6

175

804

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.9

17.5

187

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.7

17.3

209

D12

ICPC

Constipation

2.6

17.3

131

525

N02AX02

ATC

tramadol; systemic, rectal

1.4

17.2

1254

10120

R52.9

ICD-10 Finland

Pain, unspecified

1.9

17.2

249

1339

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

7.1

17.0

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

17.0

497

3313

R60.0

ICD-10 Finland

Localized oedema

1.7

17.0

378

2340

H53.1

ICD-10 Finland

Subjective visual disturbances

2.1

16.9

201

996

IGY02

NOMESCO Finland

Psychiatric monitoring contact

4.5

16.9

136

L03

ICPC

Low back symptom/complaint

1.5

16.9

658

4692

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

16.9

1100

8695

L84

ICD-10 Finland

Corns and callosities

2.6

16.9

128

513

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

16.8

1252

10133

SPAT1310

SPAT

Counselling related to known health issue

0.7

16.8

509

7103

C07AA05

ATC

propranolol; systemic

1.6

16.8

478

3165

F009, G309

ICD-10 Finland

+∞

16.7

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

6.8

16.5

XF402

NOMESCO Finland

ECG with work load test

1.7

16.5

373

2318

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

16.4

606

4269

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.6

16.3

339

5116

GD1LA

NOMESCO Finland

3.6

16.3

210

J01DA06

ATC

[U] cefuroxime; systemic

1.6

16.3

407

2601

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

16.2

751

5552

R51

ICD-10 Finland

Headache

2.4

16.2

136

575

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.6

16.1

421

2721

EBA00

SPAT

3.6

16.1

202

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

16.1

787

5882

L28

ICPC

Limited function/disability (L)

1.6

15.8

511

3485

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.3

15.8

147

654

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

15.7

476

3195

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.7

15.7

111

428

J45

ICD-10 Finland

Asthma

1.8

15.7

274

1574

N03AE01

ATC

clonazepam; systemic

2.2

15.6

169

806

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.5

15.5

123

505

H02AB07

ATC

prednisone; oral

1.6

15.5

435

2864

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

15.5

976

7639

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

15.3

410

2665

K03.64

ICD-10 Finland

Dental calculus supragingival

1.5

15.3

617

4421

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

15.2

587

4165

A01

ICPC

Pain general/multiple sites

1.9

15.1

230

1259

B01AC04

ATC

clopidogrel; oral

1.5

15.0

557

3917

R25.1

ICD-10 Finland

Tremor, unspecified

2.7

14.9

101

380

R07.3

ICD-10 Finland

Other chest pain

1.8

14.8

287

1699

A23

ICPC

Risk factor NOS

2.1

14.8

163

783

N06AG02

ATC

moclobemide; oral

2.3

14.7

140

630

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.9

14.6

228

1257

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.6

14.6

106

415

K08.3

ICD-10 Finland

Retained dental root

1.9

14.4

201

1065

G04BD12

ATC

mirabegron; oral

1.7

14.4

342

2153

G20

ICD-10 Finland

Parkinson disease

2.6

14.2

107

428

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

14.2

278

1656

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

42.7

14.1

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

14.0

481

3321

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.2

13.9

233

G46.8*I67.9

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

15.8

13.9

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

13.9

267

1578

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

2.9

13.8

307

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.1

13.8

165

820

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

4.4

13.8

112

Z01.2

ICD-10 Finland

Dental examination

1.4

13.8

956

7572

J20

ICD-10 Finland

Acute bronchitis

1.8

13.8

266

1574

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

13.8

386

2535

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.2

13.8

122

S22.3

ICD-10 Finland

Fracture of rib

1.9

13.7

202

1092

S16

ICPC

Bruise/contusion

2.4

13.7

117

500

S01

ICD-10 Finland

Open wound of head

4.1

13.7

132

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.5

13.6

553

3958

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.4

13.5

189

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

13.5

289

1764

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

4.1

13.5

129

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

13.5

404

2700

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

5.1

13.5

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.6

13.5

169

P29

ICPC

Psychological sympt/compl other

2.5

13.4

109

453

E78

ICD-10 Finland

Disorders of lipoprotein metabolism and other lipidaemias

2.4

13.4

116

500

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

13.4

452

3105

M79.1

ICD-10 Finland

Myalgia

1.6

13.4

326

2064

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.3

13.4

124

554

F32.8

ICD-10 Finland

Other depressive episodes

4.7

13.3

N05AB03

ATC

perphenazine; systemic, rectal

2.6

13.2

371

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

4.1

13.2

127

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

13.2

2437

22436

HMAK

NOMESCO Finland

0.5

13.2

1739

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.1

13.2

226

C07AB07

ATC

bisoprolol; oral

1.3

13.1

1534

13158

E0000UV

ATC

1.4

13.1

1029

8304

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

4.0

13.1

128

U02

ICPC

Urinary frequency/urgency

1.6

13.1

379

2509

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.4

13.0

840

6556

G47.3

ICD-10 Finland

Sleep apnoea

1.5

13.0

520

3704

R74

ICPC

Upper respiratory infection acute

1.5

13.0

573

4167

R13

ICD-10 Finland

Dysphagia

1.9

13.0

202

1115

G40

ICD-10 Finland

Epilepsy

5.4

13.0

N05AN01

ATC

lithium; oral

3.3

13.0

196

IGY99

NOMESCO Finland

Other psychiatric treatment contact

4.8

13.0

R20.2

ICD-10 Finland

Paraesthesia of skin

2.0

12.9

159

804

P01AB01

ATC

metronidazole; oral, rectal

1.4

12.9

1006

8107

N06AB05

ATC

paroxetine; oral

2.1

12.9

152

756

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.9

12.9

191

1036

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

12.8

1255

10471

Y94.8

ICD-10 Finland

Other leisure activity accident

2.7

12.8

317

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.2

12.8

125

573

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

4.2

12.7

117

J01EA01

ATC

trimethoprim; systemic

1.4

12.6

716

5464

R06AE07

ATC

cetirizine; oral

1.3

12.6

1048

8520

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

12.5

516

3704

WX290

SPAT

3.2

12.5

202

M19

ICD-10 Finland

Other arthrosis

2.7

12.5

304

R03BA02

ATC

budesonide; inhalant

1.5

12.4

461

3233

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.3

12.4

106

F61.0

ICD-10 Finland

Mixed personality disorders

4.3

12.4

106

EB1SA

SPAT

2.7

12.4

330

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

12.3

1018

8258

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.9

12.3

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

4.3

12.3

107

N06AA09

ATC

amitriptyline; systemic

1.6

12.3

296

1871

N06AX12

ATC

bupropion; oral

2.3

12.3

110

482

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.5

12.3

386

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.8

12.2

279

F22.0

ICD-10 Finland

Delusional disorder

3.8

12.2

132

SPAT1360

SPAT

Extensive global examination

1.8

12.2

227

1329

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

12.1

655

4946

G50.1

ICD-10 Finland

Atypical facial pain

3.3

12.1

179

G04BD08

ATC

solifenacin; oral

1.8

12.1

229

1348

R33

ICD-10 Finland

Retention of urine

1.7

12.1

247

1488

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

5.8

12.1

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

12.0

309

1981

R73

ICD-10 Finland

Elevated blood glucose level

2.4

12.0

405

SPAT1263

SPAT

Sampling

0.7

11.9

792

9812

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

11.8

355

2370

X57

ICD-10 Finland

Unspecified privation

2.7

11.8

290

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.1

11.7

137

679

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.4

11.7

556

4100

I95.1

ICD-10 Finland

Orthostatic hypotension

2.2

11.6

122

577

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

11.6

730

5655

F32.1

ICD-10 Finland

Moderate depressive episode

2.4

11.5

100

433

R63.4

ICD-10 Finland

Abnormal weight loss

2.2

11.5

113

517

D01

ICPC

Abdominal pain/cramps general

1.7

11.5

258

1596

J01AA02

ATC

doxycycline; systemic

1.3

11.5

2206

20128

M15

ICD-10 Finland

Polyarthrosis

1.9

11.5

166

893

F02.39

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

120.4

11.4

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.5

11.4

1806

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

11.4

337

2243

N01

ICPC

Headache

1.8

11.4

206

1195

J01MA06

ATC

norfloxacin; oral

1.5

11.4

400

2770

H02BX01

ATC

methylprednisolone, combinations; systemic

1.8

11.3

188

1062

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.5

11.3

364

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

11.3

185

1038

RS220

NOMESCO Finland

4.1

11.3

107

S09.9

ICD-10 Finland

Unspecified injury of head

4.0

11.2

112

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.1

11.2

191

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.3

11.2

101

447

A02BC03

ATC

lansoprazole; oral

1.3

11.2

851

6799

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

11.2

470

3377

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

11.1

606

4579

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.5

11.0

347

RK120

NOMESCO Finland

8.6

11.0

R15

ICD-10 Finland

Faecal incontinence

2.4

11.0

415

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.4

10.9

399

N03AX11

ATC

topiramate; oral

3.3

10.9

167

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.7

10.9

236

1447

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

10.9

400

2795

N06AB08

ATC

fluvoxamine; oral

2.6

10.9

317

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

10.9

1879

16814

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

5.3

10.9

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

10.8

420

2969

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.7

10.7

122

J01FA10

ATC

azithromycin; systemic

1.3

10.7

1340

11476

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

10.7

327

2192

R52.0

ICD-10 Finland

Acute pain

2.5

10.7

352

EBA00

NOMESCO Finland

Extraction of tooth

1.3

10.7

791

6286

J01DA01

ATC

[U] cefalexin; systemic

1.3

10.6

1703

15063

F31.8

ICD-10 Finland

Other bipolar affective disorders

4.1

10.6

X58

ICD-10 Finland

Exposure to other specified factors

1.6

10.5

320

2140

R01AD08

ATC

fluticasone; nasal

1.4

10.5

654

5051

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.6

10.5

270

1733

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

10.5

248

1557

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

0.6

10.5

251

3701

183

Kela drug reimbursment

Lamotrigin and topiramate

5.2

10.4

B35.1

ICD-10 Finland

Tinea unguium

1.9

10.4

148

794

B01AB05

ATC

enoxaparin; parenteral

1.3

10.4

871

7044

J01CA04

ATC

amoxicillin; systemic

1.3

10.4

2158

19728

G46.7*I67.9

ICD-10 Finland

Other lacunar syndromes

16.1

10.3

F39

ICD-10 Finland

Unspecified mood [affective] disorder

4.1

10.3

F80.1

ICD-10 Finland

Expressive language disorder

4.8

10.2

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

10.2

338

2307

N05AL01

ATC

sulpiride; systemic

3.3

10.1

155

XA400

NOMESCO Finland

EEG

5.6

10.1

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

4.0

10.1

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.3

10.0

429

S20.2

ICD-10 Finland

Contusion of thorax

2.0

10.0

130

674

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.5

10.0

337

2311

R05

ICPC

Cough

1.4

10.0

568

4317

M79.7

ICD-10 Finland

Fibromyalgia

2.4

10.0

329

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

0.4

9.9

1071

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.2

9.9

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.9

9.9

101

M03BX02

ATC

tizanidine; oral

1.3

9.9

1467

12801

N05BA12

ATC

alprazolam; oral

1.6

9.9

262

1697

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

5.0

9.8

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

4.2

9.8

P03

ICPC

Feeling depressed

1.8

9.8

158

885

L30

ICD-10 Finland

Other dermatitis

2.9

9.8

204

SPAT1262

SPAT

Handing over of treatment supplies

0.7

9.8

272

3898

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

9.8

1735

15476

R1260

NOMESCO Finland

Evaluation of communicative skills

2.7

9.8

251

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.4

9.7

351

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

9.7

252

1625

N05AA02

ATC

levomepromazine; systemic

2.1

9.6

105

506

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

9.6

199

1205

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

9.6

192

1150

R06AX27

ATC

desloratadine; oral

1.4

9.6

530

4001

D01AE16

ATC

amorolfine; topical

1.5

9.6

330

2272

R30.0

ICD-10 Finland

Dysuria

2.1

9.6

103

495

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.2

9.6

439

H02AB02

ATC

dexamethasone; systemic

0.6

9.6

107

1887

A02BA02

ATC

ranitidine; systemic

1.4

9.6

591

4549

WX290

NOMESCO Finland

Other blockade of nerve

1.3

9.6

884

7236

RS210

NOMESCO Finland

11.4

9.5

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

8.4

9.5

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

4.7

9.5

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.2

9.5

434

M54.2

ICD-10 Finland

Cervicalgia

1.8

9.5

170

987

R11

ICD-10 Finland

Nausea and vomiting

1.7

9.5

215

1335

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

9.5

308

2096

M01AX05

ATC

glucosamine; oral

1.3

9.4

656

5147

AP1

Catheterization of the left side of the heart

2.7

9.4

244

Z29.8

ICD-10 Finland

Other specified prophylactic measures

2.9

9.4

198

F01

ICD-10 Finland

Vascular dementia

17.6

9.4

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

+∞

9.4

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

9.4

291

1958

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

9.4

147

818

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

9.3

1292

11144

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

9.3

305

2078

S72.0

ICD-10 Finland

Fracture of neck of femur

1.9

9.3

127

672

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

0.6

9.3

201

3028

M01AE02

ATC

naproxen; oral, rectal

1.3

9.3

1404

12242

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.0

9.3

180

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

9.3

226

1431

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

9.2

246

1595

WX780

NOMESCO Finland

Remote monitoring CPAP

2.2

9.2

402

RS221

NOMESCO Finland

3.2

9.2

150

RK520

NOMESCO Finland

5.2

9.2

SPAT1149

SPAT

Suture or treatment of traumatic wound

0.6

9.2

177

2733

F05.8

ICD-10 Finland

Other delirium

4.4

9.2

XCK20

NOMESCO Finland

4.6

9.2

B01AB04

ATC

dalteparin; parenteral

1.8

9.2

158

903

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

9.2

230

1469

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

9.1

163

943

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

9.1

410

2980

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

2.3

9.1

337

J01FA01

ATC

erythromycin; systemic

1.5

9.0

293

1989

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.3

9.0

359

K59.01

ICD-10 Finland

Constipation outlet obstruction type

3.4

9.0

120

J01CA08

ATC

pivmecillinam; oral

1.3

9.0

997

8344

W10

ICD-10 Finland

Fall on and from stairs and steps

1.9

9.0

138

758

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

9.0

708

5653

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

9.0

167

978

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

9.0

251

1645

S70.0

ICD-10 Finland

Contusion of hip

2.0

9.0

107

536

F45.8

ICD-10 Finland

Other somatoform disorders

2.0

9.0

110

560

G43.9

ICD-10 Finland

Migraine, unspecified

2.2

8.9

419

Z76

ICD-10 Finland

Persons encountering health services in other circumstances

3.1

8.9

154

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.0

8.9

A02BC01

ATC

omeprazole; systemic

1.3

8.9

799

6503

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

8.9

214

1351

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.6

8.8

248

1629

N39

ICD-10 Finland

Other disorders of urinary system

4.1

8.8

RK110

NOMESCO Finland

3.9

8.8

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.7

8.8

102

M48.0

ICD-10 Finland

Spinal stenosis

1.4

8.8

382

2760

S06.2

ICD-10 Finland

Diffuse brain injury

3.7

8.8

R02

ICPC

Shortness of breath/dyspnoea

1.5

8.8

349

2475

130

Kela drug reimbursment

Malignant tumour

0.6

8.8

1739

P99

ICPC

Psychological disorders other

2.8

8.8

190

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

8.8

202

1261

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.4

8.8

311

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.6

8.7

248

Y94.0

ICD-10 Finland

Accident at home

2.6

8.7

248

N05BE01

ATC

buspirone; oral

2.3

8.7

340

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

8.7

846

6952

M54.3

ICD-10 Finland

Sciatica

1.8

8.7

152

873

J04.0

ICD-10 Finland

Acute laryngitis

2.5

8.7

257

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

4.7

8.7

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

2.2

8.7

397

S00.8

ICD-10 Finland

Superficial injury of other parts of head

2.9

8.7

179

F44.0

ICD-10 Finland

Dissociative amnesia

50.1

8.7

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.9

8.7

124

669

N05AF03

ATC

chlorprothixene; systemic

2.5

8.7

258

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.5

8.6

114

N05AD01

ATC

haloperidol; systemic

2.3

8.6

335

R03AC02

ATC

salbutamol; inhalant

1.3

8.6

1326

11550

UKC02

NOMESCO Finland

Cystoscopy

1.4

8.6

489

3707

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

0.8

8.6

557

6990

NB1AT

NOMESCO Finland

Puncture of shoulder with ultrasound guidance

4.6

8.6

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

8.6

270

1821

D07AC01

ATC

betamethasone; topical

1.3

8.6

885

7334

RK290

NOMESCO Finland

6.9

8.5

M54.8

ICD-10 Finland

Other dorsalgia

2.1

8.5

478

R06.5

ICD-10 Finland

Mouth breathing

1.6

8.5

196

1224

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

8.5

188

1162

WX872

NOMESCO Finland

Intensive care

1.8

8.5

143

814

XCH05

NOMESCO Finland

Eye pressure longterm registration

3.2

8.5

132

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.6

8.5

237

I50

ICD-10 Finland

Heart failure

1.9

8.5

124

674

Z02

ICD-10 Finland

Examination and encounter for administrative purposes

5.1

8.5

P74

ICPC

Anxiety disorder/anxiety state

2.5

8.4

267

D01AC02

ATC

miconazole; topical

1.6

8.4

225

1459

F01.1

ICD-10 Finland

Multi-infarct dementia

90.3

8.4

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

0.5

8.4

1524

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.4

8.4

D01BA02

ATC

terbinafine; oral; topical

1.3

8.4

634

5026

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

6.2

8.3

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

2.1

8.3

444

UJF32

NOMESCO Finland

Coloscopy

1.3

8.3

749

6091

F06.0

ICD-10 Finland

Organic hallucinosis

9.5

8.3

R39.1

ICD-10 Finland

Other difficulties with micturition

2.1

8.2

423

H91.1

ICD-10 Finland

Presbycusis

1.6

8.2

223

1451

J01FA09

ATC

clarithromycin; systemic

1.3

8.2

718

5810

J02AC01

ATC

fluconazole; systemic

1.3

8.2

871

7234

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.5

8.2

302

2110

R06AX22

ATC

ebastine; oral

1.4

8.2

350

2517

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

3.1

8.2

136

AA400

NOMESCO Finland

Electroconvulsive therapy

4.5

8.2

RK320

NOMESCO Finland

3.5

8.1

104

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.1

8.1

417

R31

ICD-10 Finland

Unspecified haematuria

1.5

8.1

293

2040

P80

ICPC

Personality disorder

8.1

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

8.1

209

1348

R21

ICPC

Throat symptom/complaint

1.4

8.0

357

2590

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.7

8.0

148

870

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

8.0

275

1891

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

8.0

144

838

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.2

8.0

356

M01AH05

ATC

etoricoxib; oral

1.2

8.0

1424

12579

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

8.0

428

3212

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.9

8.0

110

587

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.9

7.9

112

602

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.5

7.9

270

1855

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

1.8

7.9

138

794

G04BD04

ATC

oxybutynin; oral, transdermal

1.7

7.9

169

1033

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.7

7.9

164

995

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.0

7.9

145

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.3

7.9

297

N04BC05

ATC

pramipexole; oral

1.6

7.9

204

1313

R23

ICD-10 Finland

Other skin changes

3.4

7.9

107

K57

ICD-10 Finland

Diverticular disease of intestine

2.3

7.9

298

S06.3

ICD-10 Finland

Focal brain injury

3.1

7.9

129

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.6

7.8

219

1439

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.8

7.8

K05.1

ICD-10 Finland

Chronic gingivitis

1.7

7.8

151

896

F29

ICPC

Eye symptom/complaint other

1.6

7.8

194

1239

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.3

7.8

323

P76

ICPC

Depressive disorder

1.9

7.8

109

585

A01AB09

ATC

miconazole; local oral

1.5

7.8

248

1679

L01

ICPC

Neck symptom/complaint

1.4

7.8

332

2386

R2110

NOMESCO Finland

Giving the first information

1.7

7.8

161

978

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

7.8

184

1161

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

7.8

252

1714

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.4

7.7

805

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

7.7

282

1966

N06BA04

ATC

methylphenidate; oral

3.6

7.7

AN1

Coronary angiography

1.4

7.7

386

2858

R05FB02

ATC

cough suppressants and expectorants

1.3

7.7

1057

9044

WZA90

NOMESCO Finland

Other doctors statement

1.3

7.7

525

4094

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

6.4

7.7

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.7

7.7

150

895

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

7.7

170

1051

Z04

ICD-10 Finland

Examination and observation for other reasons

2.5

7.7

231

H53.8

ICD-10 Finland

Other visual disturbances

3.3

7.6

110

I11

ICD-10 Finland

Hypertensive heart disease

3.8

7.6

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.8

7.6

Z29.9

ICD-10 Finland

Prophylactic measure, unspecified

4.4

7.6

G46.8

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

18.4

7.6

H57.1

ICD-10 Finland

Ocular pain

2.2

7.6

356

F90.0

ICD-10 Finland

Disturbance of activity and attention

3.4

7.6

100

TKC22

NOMESCO Finland

Catheterisation instruction

2.3

7.6

272

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.5

7.5

242

1640

L70.2

ICD-10 Finland

Acne varioliformis

5.7

7.5

AA40B

NOMESCO Finland

4.6

7.5

L08

ICD-10 Finland

Other local infections of skin and subcutaneous tissue

2.8

7.5

156

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

7.5

179

1130

L60.0

ICD-10 Finland

Ingrowing nail

1.9

7.5

106

572

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

3.0

7.5

140

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

3.8

7.4

H02AA02

ATC

fludrocortisone; oral

3.7

7.4

F00.00

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

80.3

7.4

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

7.4

898

7566

S12

ICPC

Insect bite/sting

1.6

7.4

208

1369

D10

ICPC

Vomiting

2.0

7.4

452

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

4.2

7.4

N27

ICPC

Fear of neurological disease other

2.9

7.4

141

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

13.4

7.4

N28

ICPC

Limited function/disability (N)

2.7

7.4

173

G40.10

ICD-10 Finland

Simple partial seizures

4.1

7.4

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.9

7.3

105

568

D44.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pituitary gland

8.4

7.3

Z72.2

ICD-10 Finland

Drug use

8.4

7.3

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.3

7.3

283

F0029, G308

ICD-10 Finland

+∞

7.3

R1250

NOMESCO Finland

Evaluation of functional capability

2.5

7.3

217

H01

ICPC

Ear pain/earache

1.5

7.3

220

1472

R22

ICD-10 Finland

Localized swelling, mass and lump of skin and subcutaneous tissue

2.5

7.3

218

J01FF01

ATC

clindamycin; systemic

1.3

7.3

673

5480

H02.4

ICD-10 Finland

Ptosis of eyelid

2.0

7.3

411

SBA10

NOMESCO Finland

Measurement of excretion of saliva

4.0

7.3

A06AC51

ATC

ispaghula, combinations; systemic

1.8

7.2

130

756

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.6

7.2

191

1239

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.2

7.2

318

R52.2

ICD-10 Finland

Other chronic pain

2.0

7.2

426

J01CF05

ATC

flucloxacillin; systemic

1.9

7.2

506

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.8

7.2

112

625

WX704

NOMESCO Finland

Intubation

1.6

7.2

170

1070

WX402

NOMESCO Finland

General anaesthesia

1.4

7.2

356

2632

I63

ICD-10 Finland

Cerebral infarction

3.2

7.2

110

E03

ICD-10 Finland

Other hypothyroidism

1.7

7.2

149

908

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.1

7.2

367

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.3

7.1

260

ZXC60

NOMESCO Finland

Application of heat

2.8

7.1

150

M19.8

ICD-10 Finland

Other specified arthrosis

1.9

7.1

488

K02.2

ICD-10 Finland

Caries of cementum

1.8

7.1

118

671

T74.1

ICD-10 Finland

Physical abuse

3.4

7.1

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

7.1

321

2337

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

7.1

455

3517

C09AA05

ATC

ramipril; oral

1.3

7.0

767

6371

G43.3

ICD-10 Finland

Complicated migraine

3.6

7.0

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.0

7.0

466

XKD00

NOMESCO Finland

Uroflowmetry

1.3

7.0

462

3580

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

7.0

181

1169

DAX08

NOMESCO Finland

Fitting of hearing aid

0.5

7.0

876

N02CC04

ATC

rizatriptan; oral

2.0

7.0

441

AAF15

NOMESCO Finland

Ventriculoatrial shunt

7.0

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

2.9

6.9

130

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

6.9

295

2123

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.4

6.9

609

G04BD07

ATC

tolterodine; oral

1.6

6.9

162

1018

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

4.6

6.9

H93.1

ICD-10 Finland

Tinnitus

1.6

6.9

157

981

ZQZ00

NOMESCO Finland

Treatment of several skin areas

3.3

6.8

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.7

6.8

140

847

U05

ICPC

Urination problems other

1.7

6.8

133

795

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.8

6.8

117

673

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

5.0

6.8

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

2.1

6.8

368

S01.8

ICD-10 Finland

Open wound of other parts of head

3.0

6.8

121

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

6.8

313

2285

R07.0

ICD-10 Finland

Pain in throat

1.8

6.8

115

659

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.6

6.7

181

1179

A07DA03

ATC

loperamide; oral

1.8

6.7

104

579

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

2.3

6.7

268

H60

ICD-10 Finland

Otitis externa

1.9

6.7

505

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.8

6.7

144

ENC40

NOMESCO Finland

Uvulopalatopharyngoplasty

3.2

6.7

105

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.4

6.7

660

XX1VW

SPAT

7.2

6.7

P01

ICPC

Feeling anxious/nervous/tense

1.6

6.7

147

908

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

2.2

6.7

281

K08.80

ICD-10 Finland

Toothache NOS

1.6

6.7

147

910

WF003

NOMESCO Finland

Adjuvant radiotherapy

0.4

6.7

552

S01KA02

ATC

hypromellose; ophthalmic

2.3

6.6

262

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.1

6.6

106

A01AB04

ATC

amphotericin B; local oral

1.7

6.6

140

857

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.5

6.6

214

1453

G04BD11

ATC

fesoterodine; oral

1.9

6.6

530

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

5.2

6.6

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.6

6.6

156

984

R04.0

ICD-10 Finland

Epistaxis

1.5

6.6

208

1407

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

6.6

231

1599

R12

ICD-10 Finland

Heartburn

1.6

6.6

164

1050

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

4.0

6.6

TFN04

NOMESCO Finland

3.7

6.6

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

8.7

6.5

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

8.7

6.5

K86

ICPC

Hypertension uncomplicated

0.7

6.5

188

2682

R4150

NOMESCO Finland

Neuropsychological rehabilitation

4.8

6.5

K30

ICD-10 Finland

Functional dyspepsia

1.5

6.5

251

1769

K44

ICD-10 Finland

Diaphragmatic hernia

3.0

6.5

119

SGC10

NOMESCO Finland

Covering pulpa of tooth

1.6

6.5

142

878

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

4.1

6.5

S14

ICPC

Burn/scald

2.0

6.5

375

EB1HA

SPAT

3.7

6.5

H03AA01

ATC

levothyroxine sodium; systemic

1.3

6.4

604

4919

H25.9

ICD-10 Finland

Senile cataract, unspecified

2.3

6.4

249

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

70.0

6.4

F01.24

ICD-10 Finland

Subcortical vascular dementia other additional symptoms of mixed type

70.0

6.4

TNG34

NOMESCO Finland

Major custom moulded orthopaedic cast, knee or lower leg

2.6

6.4

160

I702, L97

ICD-10 Finland

7.4

6.4

H90.1

ICD-10 Finland

Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side

2.8

6.4

137

A02BA04

ATC

nizatidine; systemic

1.5

6.4

220

1518

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.7

6.4

117

690

H10

ICD-10 Finland

Conjunctivitis

1.7

6.3

125

750

S80.0

ICD-10 Finland

Contusion of knee

1.6

6.3

137

846

H53.2

ICD-10 Finland

Diplopia

1.9

6.3

453

N06AA06

ATC

trimipramine; systemic

2.1

6.3

312

L09

ICPC

Arm symptom/complaint

1.8

6.3

547

R26.2

ICD-10 Finland

Difficulty in walking, not elsewhere classified

2.8

6.3

139

AA1AM

NOMESCO Finland

Short MRI examination of brain with 3 Tesla magnet

9.3

6.3

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.6

6.3

156

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

18.0

6.3

F00, F03

ICD-10 Finland

+∞

6.2

F0009, G300

ICD-10 Finland

+∞

6.2

F00.1

ICD-10 Finland

Dementia in Alzheimer disease with late onset

+∞

6.2

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

2.5

6.2

189

TQW99

NOMESCO Finland

Other minor procedure on skin

1.6

6.2

152

966

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.6

6.2

164

Z00.8

ICD-10 Finland

Other general examinations

1.6

6.2

168

1099

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

6.2

680

5641

SPAT1211

SPAT

Application of soft bandage

0.6

6.2

102

1629

Z29

ICPC

Social problem NOS

2.6

6.2

165

R44.3

ICD-10 Finland

Hallucinations, unspecified

5.0

6.2

N06AX17

ATC

milnacipran; oral

3.2

6.2

H92.0

ICD-10 Finland

Otalgia

1.8

6.2

106

611

I67.2

ICD-10 Finland

Cerebral atherosclerosis

5.3

6.1

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

5.7

6.1

T78.4

ICD-10 Finland

Allergy, unspecified

1.9

6.1

486

K05.30

ICD-10 Finland

Periodontitis complex

1.4

6.1

300

2216

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.2

6.1

268

F06.4

ICD-10 Finland

Organic anxiety disorder

12.5

6.1

SPAT1301

SPAT

No procedures

0.8

6.1

621

7413

K40

ICD-10 Finland

Inguinal hernia

2.1

6.1

290

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

3.7

6.1

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

2.1

6.1

315

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

3.3

6.1

U04

ICPC

Incontinence urine

1.7

6.1

126

770

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.4

6.0

542

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

2.6

6.0

161

R00.2

ICD-10 Finland

Palpitations

1.6

6.0

161

1047

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

6.0

194

1319

101

Kela drug reimbursment

Anterior pituitary hypofunction

4.4

6.0

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

4.4

6.0

F32.0

ICD-10 Finland

Mild depressive episode

2.3

6.0

218

L12

ICPC

Hand/finger symptom/complaint

1.4

6.0

318

2377

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.2

6.0

250

RJ420

NOMESCO Finland

5.2

6.0

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

5.2

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1500

5898

3.71

302.73

3.7

3.1

2.5

mmol/l

2.94

1224

5115

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2309

12908

3.34

246.91

2.8

2.1

93.6

94.6

pmol/l

0.47

1175

6560

(3033658) Prothrombin time (PT) actual/Normal

1569

7467

3.01

214.01

4.3

3.9

84.3

85.7

1.17

1516

7281

(3019309) Folate [Moles/volume] in Red Blood Cells

1380

6176

3.05

209.41

1.6

1.8

913.5

1184.5

nmol/l

23.65

877

4566

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

172

107

16.86

204.18

1.0

705.5

794.5

ng/l

1.02

126

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

172

107

16.86

204.18

1.0

41.5

36.7

ng/l

0.46

130

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

170

107

16.65

200.58

1.0

314.3

260.6

ng/l

1.05

132

(3015377) Calcium [Moles/volume] in Serum or Plasma

1876

10339

2.77

186.46

3.0

3.4

2.4

mmol/l

0.15

1559

8806

(3024561) Albumin [Mass/volume] in Serum or Plasma

2204

13365

2.77

178.25

4.6

35.4

34.7

g/l

6.41

1973

12322

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1305

6310

2.71

162.98

4.4

4.1

205.8

535.9

ng/l

1.51

1147

5357

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1108

4969

2.80

159.87

3.2

3.1

2.6

2.4

e6/l

0.19

528

2791

(3023410) Appearance of Cerebral spinal fluid

183

203

9.46

150.94

1.5

1.4

—

(3003338) MCHC [Mass/volume]

2963

21882

3.38

150.80

30.3

22.1

330.5

331.4

g/l

5.15

2905

21670

(3021960) Folate [Moles/volume] in Serum or Plasma

1452

7686

2.53

147.06

1.7

1.6

20.5

nmol/l

0.01

1340

6432

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1133

5332

2.67

146.64

3.1

2.9

1.0

1.2

e6/l

1.00

553

3135

(3018418) pH of Serum or Plasma

1632

9316

2.42

137.56

3.3

4.0

7.4

0.19

1810

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

701

2679

3.02

133.33

2.5

2.4

31.0

40.5

u/l

2.83

575

2295

(3002385) Erythrocyte distribution width [Ratio]

2899

21984

2.91

123.67

29.2

20.4

13.9

0.04

2835

21442

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

241

468

5.46

118.49

1.4

634.5

1189.7

e6/l

0.74

151

381

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

240

467

5.45

117.72

1.3

1.4

15.8

33.6

e6/l

0.51

145

358

(3044290) Cell count panel - Cerebral spinal fluid

232

443

5.54

116.16

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

252

542

4.93

110.11

1.3

449.6

589.7

mg/l

6.21

226

520

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

814

3693

2.57

109.17

2.0

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

813

3713

2.55

107.33

2.1

1.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

232

479

5.12

106.28

1.2

3.7

3.9

mmol/l

1.83

199

447

(3009542) Hematocrit [Volume Fraction] of Blood

3002

23809

2.90

105.54

28.8

18.1

38.8

38.6

0.76

2366

15129

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

285

701

4.34

105.30

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

285

701

4.34

105.30

1.4

1.3

—

(36304419) Bacteria [Presence] in Urine

1419

8298

2.20

105.22

3.7

3.3

—

(3030467) Casts [#/volume] in Urine by Automated count

1458

8630

2.19

104.72

3.7

3.3

0.5

e6/l

0.68

989

6614

(3018095) Leukocytes [#/volume] in Urine

1684

10755

2.10

97.00

4.6

3.9

77.9

128.7

e6/l

2.85

1068

7840

(3009466) Valproate [Moles/volume] in Serum or Plasma

164

279

6.12

92.53

3.9

4.5

325.1

356.3

umol/l

1.55

141

237

(3044889) 12 lead EKG panel

2640

20196

2.27

91.97

4.7

4.3

—

(3002582) Erythrocytes [#/volume] in Urine

1507

9424

2.06

89.87

3.7

3.4

62.9

90.9

e6/l

0.86

1030

7336

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2024

14182

2.02

86.52

5.2

6.0

1.2

mmol/l

0.34

1889

12766

(3018677) aPTT in Platelet poor plasma by Coagulation assay

931

4926

2.22

85.31

2.1

2.0

29.9

30.1

0.46

902

4759

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1753

11776

1.98

83.42

2.3

2.2

77.7

79.8

nmol/l

2.52

1557

10280

(3031040) Bacteria [#/volume] in Urine by Automated count

2548

19580

2.13

82.19

6.2

5.1

613.6

2076.4

e6/l

1.40

306

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1474

9385

1.99

81.27

2.3

2.1

248.3

222.0

u/l

0.40

1375

8733

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2147

15648

1.97

78.52

6.1

6.8

1.2

mmol/l

1.20

1963

13132

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

495

2044

2.66

78.44

1.9

1.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

674

3214

2.36

78.42

2.3

2.7

7.9

9.5

umol/l

1.34

539

2808

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3020

25082

2.54

77.33

5.9

4.9

1.9

2.1

mu/l

3.66

2803

22445

(3037467) Urinalysis macro (dipstick) panel - Urine

2568

20008

2.08

76.65

5.7

4.7

—

(40758558) Short blood count panel - Blood

1198

7232

2.00

75.66

6.4

6.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2329

17769

1.94

70.55

4.8

4.7

6.7

6.8

mmol/l

2.02

2139

16670

(3016018) Differential panel - Cerebral spinal fluid

133

242

5.67

69.87

1.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3166

27468

2.69

63.53

21.9

16.7

28.1

25.9

mg/l

3.09

2598

22398

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2745

22528

2.03

62.45

7.3

7.7

80.5

80.7

u/l

0.05

2561

21092

(3024891) Influenza virus A+B Ag [Presence] in Specimen

216

638

3.54

61.13

1.3

1.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

372

1509

2.64

60.37

3.2

3.6

24.0

24.2

mmol/l

0.45

332

1338

(3018010) Neutrophils/100 leukocytes in Blood

1838

13431

1.78

59.13

6.0

5.8

58.7

58.2

0.93

1694

12424

(3022096) Basophils/100 leukocytes in Blood

1789

12988

1.78

58.69

5.9

0.7

0.02

1640

12003

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2560

20729

1.89

57.67

4.1

4.0

14.6

15.1

pmol/l

20.47

2305

18466

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

901

5334

1.93

57.36

2.1

1.9

—

(3006504) Eosinophils/100 leukocytes in Blood

1818

13331

1.76

56.95

5.9

2.8

0.04

1664

12305

(3019069) Monocytes/100 leukocytes in Blood

1824

13399

1.76

56.68

6.1

6.2

8.8

8.9

0.72

1676

12405

(3026008) Bacteria identified in Urine by Culture

1457

10074

1.77

55.64

4.0

3.5

—

(3002030) Lymphocytes/100 leukocytes in Blood

1841

13638

1.74

54.80

6.0

26.1

26.5

0.79

1695

12560

(42870588) Differential panel, method unspecified - Blood

1441

10017

1.75

53.36

5.1

5.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

551

2836

2.12

51.37

5.1

6.2

1.3

1.4

mmol/l

0.51

524

2717

(3019550) Sodium [Moles/volume] in Serum or Plasma

3225

28818

2.63

50.11

26.1

20.0

139.5

mmol/l

0.13

3149

28067

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

389

1754

2.37

50.00

6.0

8.3

24.6

24.4

mmol/l

0.46

350

1624

(3023103) Potassium [Moles/volume] in Serum or Plasma

3226

28871

2.61

49.22

26.4

20.2

4.0

mmol/l

17.48

3144

28072

(3001604) Monocytes [#/volume] in Blood

1864

14127

1.69

48.65

5.7

5.5

0.6

e9/l

0.12

1440

11984

(3006315) Basophils [#/volume] in Blood

1871

14196

1.69

48.61

5.7

5.6

0.0

e9/l

0.06

1447

12060

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1818

13690

1.69

48.61

3.0

2.4

—

(3019198) Lymphocytes [#/volume] in Blood

1890

14458

1.67

46.89

5.8

5.7

1.9

e9/l

0.27

1489

12509

(3000991) Gas panel - Venous blood

518

2690

2.09

46.87

5.5

7.4

—

(40761511) CBC panel - Blood by Automated count

3155

28068

2.33

46.86

17.9

16.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1197

8161

1.71

45.69

2.4

2.3

2.5

3.1

mg/l

14.98

979

6941

(3023368) Bacteria identified in Blood by Culture

1288

8961

1.69

45.57

5.2

4.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1033

6776

1.75

45.24

3.3

3.9

—

(3013115) Eosinophils [#/volume] in Blood

1902

14654

1.66

45.20

6.3

5.8

0.2

e9/l

0.06

1495

12644

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

104

6.65

42.52

2.1

2.2

53.8

51.5

umol/l

0.21

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1566

11647

1.63

41.54

3.1

2.8

106.0

148.7

ug/l

18.02

1449

10559

(3013650) Neutrophils [#/volume] in Blood by Automated count

2082

16626

1.63

41.06

8.3

8.8

4.3

4.2

e9/l

0.58

1662

14398

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

442

2267

2.09

41.01

1.8

1.7

1.6

0.27

373

1931

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

568

3200

1.93

40.37

2.3

3.1

236.9

251.1

ng/l

0.25

521

2917

(3026782) Osmolality of Urine

951

6266

1.71

40.11

2.8

570.1

538.2

mosm/kgh2o

4.24

685

5341

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1224

8654

1.64

39.21

3.1

39.1

37.3

u/l

0.18

1105

8164

(3029937) Albumin [Presence] in Urine by Test strip

435

7665

0.51

38.46

5.0

4.5

0.0

estimate

1.08

108

2564

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2053

16538

1.59

37.30

3.4

3.1

48.3

55.0

u/l

2.03

1848

15040

(3035941) MCH [Entitic mass]

3259

29869

2.43

37.12

31.3

24.6

30.4

0.70

3195

29324

(3024731) MCV [Entitic volume]

3259

29870

2.43

37.10

31.4

24.7

91.6

0.05

3195

29326

(3026361) Erythrocytes [#/volume] in Blood

3259

29871

2.43

37.08

31.5

24.7

4.4

e12/l

2.71

3146

28870

(3010813) Leukocytes [#/volume] in Blood

3259

29876

2.43

36.98

31.5

24.8

6.9

e9/l

0.33

3147

28864

(3007461) Platelets [#/volume] in Blood

3258

29864

2.43

36.95

31.4

24.7

239.0

243.7

e9/l

3.94

3158

28977

(3000963) Hemoglobin [Mass/volume] in Blood

3259

29879

2.43

36.92

31.7

24.9

131.4

133.0

g/l

8.34

3196

29349

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3192

29041

2.20

36.42

12.3

11.3

25.2

24.9

u/l

0.12

3061

27791

(1761868) Lipid panel - Serum or Plasma

483

8097

0.53

35.90

3.0

3.2

—

(3036489) Thrombin time

234

987

2.47

34.55

1.9

21.9

21.6

0.14

211

884

(1002224) Polysomnography panel

188

733

2.65

32.66

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

224

957

2.43

32.14

3.2

3.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1938

15693

1.53

32.12

5.1

6.2

12.3

12.0

umol/l

0.42

1798

14893

(3022217) INR in Platelet poor plasma by Coagulation assay

730

4748

1.68

31.17

34.0

29.7

1.4

1.5

inr

0.47

665

(3021589) Normoblasts [#/volume] in Blood

1597

12468

1.52

31.01

7.9

10.3

0.0

e9/l

0.08

1112

10127

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2904

25923

1.73

30.70

6.6

6.5

40.0

40.7

mmol/mol

3.12

2711

23558

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

220

953

2.40

30.60

2.0

2.4

0.0

g/l

0.00

185

885

(3013707) Erythrocyte sedimentation rate by Westergren method

2460

21096

1.57

30.50

4.1

4.3

13.1

14.2

mm/h

3.04

2250

19294

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

135

4.96

30.48

1.1

1.0

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

611

3820

1.73

30.09

5.9

6.8

5.1

kpa

0.09

562

3619

(3027801) Oxygen [Partial pressure] in Arterial blood

611

3820

1.73

30.09

5.9

6.8

11.9

12.0

kpa

0.26

560

3621

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

220

964

2.37

29.82

2.0

2.4

0.0

g/l

0.50

185

886

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

187

763

2.53

29.60

1.2

—

(3003396) Base excess in Arterial blood by calculation

608

3813

1.72

29.56

5.9

6.8

0.9

1.1

mmol/l

0.81

488

2941

(3002032) Base excess in Venous blood by calculation

515

3085

1.79

29.40

3.1

3.5

1.6

2.0

mmol/l

1.55

423

2470

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2991

27008

1.76

29.23

5.1

6.0

mmol/l

0.38

2705

24083

(3013512) EKG study

634

9428

0.60

28.97

4.2

4.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

187

773

2.50

28.80

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

227

1024

2.30

28.77

2.0

2.4

0.0

0.1

g/l

0.43

190

943

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3032

27530

1.79

28.47

5.6

5.4

2.5

2.6

mmol/l

6.25

2790

24816

(42529406) Shigella sp [Presence] in Stool by Culture

187

778

2.48

28.40

1.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

512

3101

1.76

28.05

3.1

3.4

5.8

kpa

0.04

478

3003

(3024354) Oxygen [Partial pressure] in Venous blood

438

2546

1.82

27.53

2.6

2.9

4.5

kpa

0.09

402

2458

(3012544) pH of Venous blood

520

3208

1.73

26.60

3.1

3.5

—

7.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

707

4735

1.62

26.38

1.4

1.5

2.5

2.6

g/l

0.32

307

2742

(36660697) Celiac disease serology panel - Serum

346

1897

1.91

26.08

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

869

6154

1.55

25.37

1.9

1.7

1.4

mg/l

0.09

643

4785

(3000850) Epithelial cells [#/volume] in Urine

927

6675

1.53

25.02

2.5

2.7

5.0

5.2

e6/l

0.21

751

5858

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

771

5333

1.57

24.92

1.3

1.2

3.0

1.6

u/ml

0.92

1343

(3012095) Magnesium [Moles/volume] in Serum or Plasma

741

5093

1.58

24.58

2.4

3.0

0.8

mmol/l

1.20

633

4707

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

773

10679

0.64

24.56

4.7

4.4

—

(3024928) Oxygen saturation in Venous blood

159

658

2.48

24.43

1.9

2.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

189

3836

0.46

23.81

5.0

4.8

32.7

33.5

0.45

136

2479

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

308

1675

1.92

23.73

2.3

2.4

29.1

26.2

au/ml

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

223

1085

2.13

23.43

2.0

2.3

37.1

37.3

g/l

0.10

187

933

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

226

1107

2.11

23.33

2.3

2.2

833.2

552.1

ug/l

0.41

209

1051

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

282

1513

1.94

22.60

1.2

1.3

47.7

59.4

au/ml

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

172

3.89

22.47

2.3

2.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

218

1080

2.09

21.84

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

231

1172

2.04

21.70

2.1

2.5

0.6

1.1

g/l

2.05

192

1009

(3000492) Spirometry study

385

2316

1.74

21.30

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

360

5790

0.58

21.16

4.3

4.5

—

(40761536) Microorganisms panel - Urine sediment

100

2497

0.38

21.04

4.9

4.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

139

582

2.45

20.85

2.1

2.6

28.9

35.7

umol/l

1.89

113

474

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

208

3890

0.51

20.40

8.4

7.9

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

805

5847

1.49

20.15

3.3

0.8

ug/l

0.02

566

4152

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

200

990

2.08

20.08

1.1

—

0.9

—

(3051611) Lipemic interference index of Serum or Plasma

347

2.85

19.94

3.0

3.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

241

1281

1.95

19.83

2.1

2.4

3.1

g/l

0.24

191

1021

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

243

1299

1.94

19.66

2.1

2.4

10.3

10.4

g/l

0.03

197

1108

(3004789) Transferrin [Mass/volume] in Serum or Plasma

675

4755

1.52

19.51

2.2

2.5

2.2

2.3

g/l

1.90

622

4370

(3014576) Chloride [Moles/volume] in Serum or Plasma

593

4108

1.53

18.43

6.4

6.3

104.5

104.2

mmol/l

0.94

586

4002

(3027945) Reticulocytes/100 erythrocytes in Blood

576

3983

1.53

18.02

2.0

2.4

1.8

0.68

478

3506

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2829

25924

1.49

17.96

21.3

16.1

75.1

73.6

ml/min/173m2

3.42

2267

21551

(3022948) Iron [Moles/volume] in Serum or Plasma

703

5081

1.48

17.75

2.2

2.5

11.7

12.3

umol/l

1.41

648

4674

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

248

1380

1.86

17.73

2.1

2.4

7.3

7.5

g/l

1.27

192

1037

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

247

1376

1.86

17.60

2.1

2.4

3.8

g/l

0.04

190

1002

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

247

1378

1.85

17.52

2.1

2.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

150

703

2.18

17.35

2.4

2.3

189.3

201.0

0.90

138

668

(3003327) Ova and parasites identified in Stool by Light microscopy

151

710

2.18

17.33

1.7

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

628

4468

1.49

17.08

2.4

2.6

20.9

21.8

0.85

526

3791

(3000494) Fungus identified in Specimen by Culture

488

3293

1.56

16.98

1.6

1.4

—

(3015736) pH of Urine

1341

10947

1.37

16.75

3.5

3.8

—

5.9

—

(3017181) Myelocytes/100 leukocytes in Blood

124

2587

0.46

16.54

4.3

4.0

0.9

0.12

793

(1001926) Buprenorphine [Presence] in Urine by Screen method

281

2.85

16.47

6.2

1.8

—

(3021440) Promyelocytes/100 leukocytes in Blood

116

2464

0.45

16.24

4.1

4.0

0.2

0.1

0.31

738

(3028707) Methadone [Presence] in Urine by Screen method

161

3.45

15.89

8.2

2.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

294

1778

1.71

15.84

7.5

9.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

179

928

1.98

15.84

1.8

1.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

108

2334

0.45

15.83

3.7

3.8

0.4

0.6

0.70

562

(3019225) pH of Specimen

182

3289

0.53

15.76

3.8

4.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1034

8163

1.38

15.67

4.9

4.7

22.9

22.0

0.88

406

4316

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

387

2527

1.60

15.44

3.1

3.7

90.5

95.6

ng/l

0.60

325

2133

(3041096) Erythrocytes [Presence] in Urine by Automated

530

7337

0.67

15.35

4.1

3.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

362

2331

1.62

15.30

1.7

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

154

767

2.05

15.24

2.1

93.4

88.8

1.59

144

726

(3025159) Blasts/100 leukocytes in Blood

107

2286

0.45

15.20

4.2

4.0

1.4

0.3

0.36

611

(3048689) Calprotectin [Mass/mass] in Stool

426

2861

1.56

15.04

2.1

2.0

107.3

144.3

ug/g

1.93

329

2180

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

246

2.88

14.95

1.2

1.1

—

2.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

141

2700

0.50

14.63

3.2

3.8

1.2

mmol/l

0.18

122

2361

(3011288) Drugs identified in Urine by Screen method

234

2.90

14.48

7.5

2.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

939

7395

1.37

14.18

2.5

2.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

271

1657

1.69

14.01

1.7

1.8

1.5

g/l

0.09

222

1430

(3044640) Blood type and Crossmatch panel - Blood

1175

9609

1.34

13.77

2.7

2.6

—

(3051651) Icteric interference index of Serum or Plasma

180

3.09

13.34

2.9

3.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

4.15

13.20

2.3

2.7

27.3

29.0

umol/l

0.34

(3006653) Thiamine [Moles/volume] in Blood

123

3.53

12.92

1.2

129.5

145.2

nmol/l

0.86

123

(3042936) Bacteria identified in Isolate by Culture

593

4382

1.43

12.91

2.1

2.0

—

(3016879) Cocaine [Presence] in Urine

334

2.46

12.68

6.0

1.8

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

148

786

1.92

12.26

2.3

3.5

3.6

g/l

0.38

140

745

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

939

7561

1.33

11.88

1.6

1.3

mmol/l

0.15

879

6218

(3019832) Treponema pallidum Ab [Presence] in Serum

186

1073

1.77

11.85

1.5

—

(3027008) Opiates [Presence] in Urine

360

2.34

11.65

5.9

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

360

2.34

11.65

6.0

1.7

—

(3028300) Cannabinoids [Presence] in Urine

362

2.32

11.51

6.1

1.7

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

288

1886

1.57

11.29

5.1

6.5

25.1

25.0

mmol/l

0.22

288

1873

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

204

1232

1.70

11.06

2.6

2.9

0.3

u/ml

0.06

106

732

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

314

2.39

10.94

1.2

6.2

5.7

u/ml

0.06

144

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

120

618

1.98

10.91

1.3

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

204

2.72

10.72

1.2

1.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

419

3000

1.45

10.72

1.7

1.6

—

(3027944) Amphetamines [Presence] in Urine

355

2.28

10.69

6.3

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

360

2.25

10.35

3.8

3.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

471

3479

1.41

10.13

2.0

1.8

—

(3032080) INR in Blood by Coagulation assay

1527

13337

1.26

9.79

11.0

1.3

inr

0.29

226

3709

(3000570) Elastase.pancreatic [Mass/mass] in Stool

153

883

1.77

9.78

1.4

263.0

271.3

ug/g

0.18

532

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

205

2.61

9.56

1.3

1.2

90.0

145.8

titre

—

(4198724)

4.80

9.53

2.5

1.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

548

4196

1.36

9.45

4.2

5.4

1.0

mmol/l

1.80

469

3872

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

125

3.06

9.23

1.9

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

141

2.93

9.22

1.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

425

3139

1.40

9.11

6.9

7.5

119.4

119.9

g/l

0.20

409

3022

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

426

3149

1.40

9.09

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

235

2.45

9.03

1.6

1.4

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

3.84

8.95

1.7

2.1

171.0

200.7

0.45

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.56

8.94

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

102

3.26

8.88

1.3

2.5

119.1

95.1

umol/l

0.25

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

327

2.20

8.75

1.2

9.7

3.1

u/ml

0.75

101

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2810

26570

1.30

8.26

4.3

4.7

1.4

1.5

mmol/l

3.10

2522

23888

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

156

2.71

8.24

1.2

1.1

32.9

47.0

mg/l

2.35

131

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1181

10160

1.25

8.23

5.3

5.6

4.1

4.0

ug/l

0.02

1032

9040

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

265

1844

1.47

7.85

1.6

1.5

—

(3016502) Oxygen saturation in Arterial blood

449

3430

1.35

7.79

6.7

7.1

95.3

95.4

0.15

427

3294

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

569

0.24

7.64

3.7

3.6

61.4

58.5

0.40

569

(40768797) Stomach Pathology biopsy report

523

4099

1.32

7.63

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

146

2.69

7.57

1.2

1.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

342

2522

1.39

7.38

1.9

2.2

398.6

376.8

nmol/l

1.02

303

2290

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2823

26810

1.28

7.34

4.4

4.7

4.4

4.5

mmol/l

5.45

2563

24288

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

184

1206

1.56

7.25

2.0

1.9

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

220

1500

1.50

7.22

2.4

3.2

4.3

4.4

pmol/l

0.73

181

1306

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2715

25681

1.26

7.19

3.8

4.2

1.3

mmol/l

0.66

2380

22867

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

162

2.55

7.17

1.3

1.4

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

169

2.50

7.08

1.3

1.5

13.9

14.4

umol/l

0.18

158

(3022313) Gas panel - Capillary blood

1513

0.55

6.97

3.9

3.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

127

2021

0.61

6.78

3.5

3.6

1.6

2.0

mmol/l

0.79

1485

(4268621)

217

2.28

6.71

2.1

2.3

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

4.46

6.70

1.3

116.3

113.0

ug/l

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

5.02

6.70

2.3

1.9

14.9

17.5

umol/l

0.45

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

136

2123

0.63

6.69

3.5

3.6

5.1

5.2

kpa

0.20

121

1948

(4306422)

303

2.07

6.66

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

400

1.92

6.63

1.2

1.1

—

(3039000) Anion gap in Blood

120

728

1.67

6.52

6.9

7.4

11.2

11.1

mmol/l

0.17

107

646

(3018572) Chloride [Moles/volume] in Blood

120

728

1.67

6.52

6.9

7.4

105.5

105.1

mmol/l

0.39

107

646

(3009343) pH of Capillary blood

135

2098

0.63

6.52

3.4

3.6

7.4

0.14

272

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

166

2.43

6.35

1.2

32.1

19.5

u/l

0.75

139

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1357

0.55

6.32

2.0

1.9

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

544

4393

1.28

6.29

1.3

45.0

39.0

iu/ml

0.20

135

1341

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

143

2.53

6.27

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

225

2.19

6.19

1.1

1.2

93.9

94.6

0.06

213

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

179

1212

1.50

6.12

3.1

3.2

308.8

4346.0

u/ml

1.05

137

1023

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

377

2909

1.33

6.10

2.0

2.1

0.2

g/l

2.55

320

2696

(3026493) Urate [Moles/volume] in Serum or Plasma

924

7947

1.22

6.09

2.4

2.9

11521.3

6125.7

umol/l

1.62

746

6717

(3014891) Appearance of Pleural fluid

3.46

6.00

1.4

1.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

376

2907

1.33

6.00

2.1

2.6

65.7

66.2

g/l

0.63

325

2624

(3036603) Volume of Urine

196

2.26

5.98

1.4

1488.5

1660.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

310

2331

1.36

5.95

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

171

1155

1.51

5.92

1.1

1.0

—

(3047181) Lactate [Moles/volume] in Blood

153

1009

1.54

5.92

6.5

6.4

1.4

1.3

mmol/l

0.70

137

889

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

3.12

5.88

1.1

1.2

181.5

114.8

nmol/l

0.61

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

102

613

1.68

5.78

1.2

1.1

5.9

11.1

u/ml

0.46

(1616796) Gas panel - Central venous blood

770

0.44

5.77

4.0

3.9

—

(3028717) Thiamine [Mass/volume] in Blood

5.01

5.74

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

175

2.30

5.69

1.2

114.4

91.7

u/l

0.48

149

(4027681)

109

2.67

5.65

1.4

1.2

—

(40768804) Tissue Pathology biopsy report

1307

11683

1.19

5.62

2.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

252

1851

1.39

5.60

1.4

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

716

0.43

5.54

1.8

3.3

20.9

953.3

u/ml

1.65

655

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

304

1.96

5.54

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

128

2.51

5.53

1.2

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

276

0.22

5.48

4.2

1.6

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

117

2.58

5.45

1.8

2.4

97.5

98.2

0.03

111

(3004809) Band form neutrophils/100 leukocytes in Blood

579

0.38

5.37

2.5

3.8

1.3

1.4

0.11

441

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

296

1.94

5.25

1.1

119.3

114.3

0.53

262

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

147

989

1.51

5.23

1.2

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

392

1.80

5.12

1.3

—

(3025130) Human papilloma virus identified in Specimen

190

2.17

5.12

1.5

1.7

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1251

0.58

5.11

1.8

—

(40761535) Cells panel - Urine sediment

191

2636

0.71

5.07

3.7

3.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

478

3899

1.26

5.06

3.4

4.0

254.3

248.1

u/l

0.27

433

3670

(3013290) Carbon dioxide [Partial pressure] in Blood

757

0.47

5.05

4.1

4.7

5.0

kpa

0.01

745

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

158

1087

1.48

5.05

2.1

1.8

—

(3012501) Base excess in Blood by calculation

756

0.47

5.03

4.1

4.7

2.5

2.8

mmol/l

0.27

523

(3035350) Ketones [Presence] in Urine by Test strip

1533

13994

1.17

4.92

3.7

4.0

0.0

estimate

0.00

107

2671

(40767503) Oxygen content in Capillary blood by calculation

762

0.48

4.91

3.2

2.5

16.9

15.7

0.82

399

(3005011) Chlamydia sp Ab [Titer] in Serum

4.07

4.89

2.1

1.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

794

0.50

4.77

2.4

202.3

92.7

ug/min

0.44

473

(3044941) Cell count panel - Synovial fluid

493

1.68

4.71

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

331

2605

1.30

4.67

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

140

2.30

4.61

1.6

1.2

—

(3009261) Glucose [Presence] in Urine by Test strip

1550

14212

1.16

4.60

3.8

4.1

0.0

estimate

1.08

105

2625

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1262

0.61

4.56

4.1

3.9

24.7

24.9

mmol/l

0.15

1155

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

550

0.41

4.55

2.8

3.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

116

2.43

4.54

1.4

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

341

1.80

4.53

1.5

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

202

1485

1.38

4.52

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

469

1.68

4.50

2.2

1.6

280.4

282.9

mu/l

0.03

431

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

570

6704

0.82

4.41

1.6

1.7

21414598.8

25005066.6

pmol/l

0.06

495

5403

(3021601) Nitrite [Presence] in Urine by Test strip

1529

14036

1.16

4.40

5.9

5.4

0.0

estimate

0.00

112

2681

(4146454)

366

0.30

4.38

1.6

2.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.72

4.36

1.2

1.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

376

3040

1.27

4.29

2.2

2.5

4.8

7.1

ug/l

4.17

308

2651

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

8.91

4.28

6.5

10.9

—

(3042631) Mycobacterium sp identified in Specimen

490

0.40

4.22

5.9

2.7

—

(3020891) Body temperature

1332

0.64

4.18

4.5

—

(3037522) Nuclear Ab [Titer] in Serum

413

3387

1.25

4.17

1.3

552.2

557.8

titre

0.02

759

(4034850)

935

0.57

4.14

7.7

11.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

188

2.03

4.08

1.7

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

188

2.03

4.08

1.7

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

368

1.73

4.07

1.1

—

(21494755) Public health laboratory ask at order entry panel

1190

0.62

4.07

1.3

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

3.20

4.05

1.3

1.9

—

(3019150) Specific gravity of Urine by Refractometry

528

6208

0.82

4.04

4.3

4.5

1.0

kg/l

0.95

989

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

461

1.64

4.02

2.0

1.7

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

10.02

4.01

1.6

1.1

547.8

239.7

nmol/l

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

566

1.57

3.92

2.0

1.8

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

3.43

3.90

1.1

120.2

82.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.18

3.88

1.6

1.4

—

(3045788) Cell count panel - Pleural fluid

374

1.70

3.86

2.0

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

710

0.53

3.82

4.2

3.8

35.7

28.0

mg/l

0.57

454

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

223

0.27

3.74

3.8

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

402

1.65

3.69

1.0

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

5.64

3.65

1.3

1.1

—

(3021901) Oxygen saturation in Capillary blood

683

0.54

3.60

3.1

2.9

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

150

2.08

3.56

2.4

1.6

14.3

16.7

nmol/l

1.30

136

(3017446) Testosterone [Moles/volume] in Serum or Plasma

230

1791

1.30

3.56

2.3

2.1

13.3

11.9

nmol/l

1.39

206

1548

(40768443) Skin Pathology biopsy report

180

1354

1.35

3.55

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1407

0.68

3.48

2.4

1.9

0.8

2.1

ug/l

2.70

1237

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

152

2.05

3.45

1.4

1.5

6.3

7.5

u/l

0.39

130

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

555

0.50

3.43

1.9

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

466

1.58

3.41

1.4

1.3

28.0

30.7

iu/l

0.30

386

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

2.58

3.38

1.1

104.6

99.0

0.19

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

389

1.63

3.37

1.1

1.3

122.2

124.1

u/ml

0.06

(3044242) Glucose [Moles/volume] in Arterial blood

194

0.26

3.36

1.2

2.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

442

0.45

3.33

2.3

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

183

1400

1.32

3.24

5.7

5.3

0.9

1.84

169

1311

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.51

3.20

1.1

—

(3049717) Cytology report of Urine Cyto stain

178

1360

1.33

3.19

2.3

2.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

803

0.60

3.12

3.0

2.9

7.9

7.8

kpa

0.03

741

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.54

3.12

1.1

88.3

79.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

181

1.89

3.05

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

722

0.59

3.03

1.7

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

300

1.68

3.02

1.2

60.5

58.9

u/l

0.04

199

(3015235) Bicarbonate [Moles/volume] in Capillary blood

902

0.64

2.97

2.8

3.2

24.7

25.1

mmol/l

0.47

788

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.47

2.95

1.1

1.3

82.0

80.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.15

2.93

2.1

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

296

2438

1.23

2.92

2.3

2.4

—

(3010421) pH of Blood

873

0.64

2.91

3.5

4.4

7.4

0.31

745

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

430

0.49

2.88

2.0

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

4.10

2.88

1.0

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

172

1.87

2.81

1.1

2.4

8.4

nmol/l

—

(3003181) Sodium [Moles/volume] in Urine

640

1.43

2.75

1.4

1.3

59.1

60.5

mmol/l

0.13

510

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

748

0.62

2.70

1.6

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

437

1.52

2.69

1.7

1.5

61296.0

77657.5

e6/l

0.12

262

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

105

2.10

2.68

1.1

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

220

1772

1.26

2.68

2.5

—

(3034426) Prothrombin time (PT)

2.34

2.65

1.1

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

102

738

1.39

2.64

1.9

1.5

0.2

g/l

0.36

699

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

429

0.51

2.64

2.0

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

655

1.42

2.61

1.7

1.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1469

13771

1.12

2.59

3.8

4.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

177

1.82

2.59

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

177

1.82

2.59

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

177

1.82

2.59

1.0

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

7.15

2.55

1.2

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

128

1.96

2.55

1.6

1.0

1.2

u/l

1.85

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

178

1408

1.28

2.53

5.8

5.2

1.7

1.6

1.07

165

1318

(3008757) Leukocyte morphology finding [Identifier] in Blood

355

0.48

2.51

3.3

4.3

—

(4035726)

230

2798

0.81

2.50

1.3

1.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

413

1.51

2.49

6.3

6.4

11.9

12.2

mg/l

0.17

383

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

180

1.78

2.47

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

180

1.78

2.47

1.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

180

1.78

2.47

1.0

1.1

—

(3021788) Differential panel - Synovial fluid

562

1.43

2.46

1.4

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

439

1.49

2.45

1.1

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

480

1.47

2.45

1.7

1.5

853.3

1704.5

e6/l

3.03

350

(3005719) IgG [Mass/volume] in Serum or Plasma

246

2029

1.23

2.44

1.9

2.7

10.4

10.7

g/l

0.32

222

1837

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

480

0.56

2.42

1.9

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

110

2.01

2.40

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

737

0.65

2.38

2.7

1.4

1.7

mg/l

3.30

651

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

722

0.65

2.35

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

176

1.77

2.33

1.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

103

764

1.36

2.33

1.9

1.5

1.2

g/l

0.11

725

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

133

1.89

2.31

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

3.22

2.30

9.3

9.8

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

134

1718

0.77

2.30

2.4

2.8

0.3

e6/l

0.04

128

1683

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.11

2.22

1.2

—

(3016038) Potassium [Moles/volume] in Urine

225

1.65

2.20

1.1

31.4

35.2

mmol/l

0.54

189

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

272

1.59

2.20

1.2

1.1

2.0

2.3

u/ml

0.09

(4010399)

251

2103

1.21

2.16

1.4

—

(3045424) Erythrocytes [Presence] in Urine

495

0.60

2.07

1.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.00

2.05

0.0

2.6

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

271

1.56

2.00

1.3

1.5

17.1

23.8

u/ml

0.87

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.15

1.98

1.3

—

(3022806) Fractional oxyhemoglobin in Capillary blood

463

0.60

1.97

2.2

1.8

88.7

89.3

0.29

458

(3023487) Leukocytes [#/volume] in Peritoneal fluid

105

1.91

1.95

1.6

2.2

8306.8

1011.9

e6/l

0.43

(3017569) Oxygen content in Arterial blood

185

0.43

1.92

1.8

2.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

100

764

1.32

1.92

1.5

1.6

11669.4

14526.0

e6/l

0.52

546

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

128

1.80

1.89

1.0

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

499

1.39

1.88

1.3

1.2

32.4

39.2

u/ml

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.65

1.86

1.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

904

0.72

1.85

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.94

1.84

1.4

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

1.94

1.84

1.7

2.0

20561.9

26682.5

e6/l

0.11

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

290

0.52

1.84

1.2

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

404

0.59

1.83

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

353

0.56

1.82

2.6

3.8

63.0

59.0

0.26

215

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

365

0.57

1.81

2.1

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

385

1.44

1.81

1.1

1.2

304.5

283.9

u/ml

0.22

231

(3000012) Reticulocyte production index

181

0.44

1.81

1.1

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

182

0.44

1.81

8.9

3.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

402

0.59

1.80

1.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.58

1.80

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

3.05

1.80

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

437

0.61

1.77

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

421

1.41

1.76

1.2

1.3

197.4

223.4

miu/ml

0.23

164

(3036071) Salmonella sp Ab [Titer] in Serum

2.09

1.75

1.1

—

(3033799) Differential panel - Peritoneal fluid

1.90

1.75

1.6

2.0

—

(3029075) Extractable nuclear Ab panel - Serum

2.03

1.75

1.0

—

(4212803)

2.50

1.74

1.3

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

576

1.34

1.73

1.2

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

206

2432

0.84

1.71

2.5

2.8

67.7

59.9

ml/min/173m2

2.20

1082

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.30

1.70

1.0

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

561

1.34

1.69

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

1.68

0.0

2.7

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

203

1.58

1.68

2.0

1.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

114

906

1.27

1.66

3.4

3.1

0.7

0.8

nmol/l

4.20

683

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

162

0.43

1.66

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

119

1.77

1.66

6.0

5.6

80.6

64.1

mg/l

0.53

(3025468) Yersinia sp identified in Specimen by Organism specific culture

404

0.62

1.65

1.2

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

112

1.79

1.64

1.2

1.3

—

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

264

0.53

1.62

1.3

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

264

0.53

1.62

1.3

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

264

0.53

1.62

1.3

1.5

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.57

1.61

1.0

—

(3042517) Benzodiazepines panel - Urine

3.57

1.61

20.6

1.9

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

706

1.30

1.61

1.4

1.7

2.9

3.9

mg/l

0.44

527

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.15

1.61

1.0

1.1

—

(3045414) Leukocytes [Presence] in Urine

105

1318

0.79

1.60

2.1

1.9

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

412

0.63

1.59

2.0

1.9

21.8

25.7

ug/l

0.25

405

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

113

1404

0.80

1.58

1.6

1.8

—

(3044007) Cell count panel - Peritoneal fluid

1.89

1.54

2.3

1.9

—

(40768793) Breast Pathology biopsy report

669

0.71

1.54

1.1

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

322

0.59

1.53

2.0

3.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

407

0.64

1.51

1.2

1.3

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

0.00

1.51

0.0

1.3

—

7.8

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.16

1.50

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

393

0.63

1.49

1.8

1.7

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

294

0.58

1.48

1.2

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

535

0.69

1.47

1.7

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

411

1.37

1.46

1.1

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

299

2637

1.15

1.46

1.7

1.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

179

1.57

1.45

1.7

1.6

3.6

7.0

u/l

0.77

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

402

0.64

1.45

1.2

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.12

1.44

1.0

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.12

1.44

1.0

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

542

1.32

1.44

1.6

31.0

31.3

g/l

0.06

484

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

3.13

1.44

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

2.04

1.43

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

105

1297

0.80

1.42

1.2

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

110

1.73

1.42

2.4

2.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

180

1.56

1.42

1.1

1.2

12.2

11.9

mmol/l

0.07

(3006922) Hepatitis E virus Ab [Presence] in Serum

149

1.61

1.40

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

580

1.30

1.39

1.6

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.90

1.39

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.90

1.39

1.0

1.1

—

(3012441) Differential panel - Pleural fluid

416

1.35

1.37

1.8

1.5

—

(40768795) Lymph node Pathology biopsy report

285

0.59

1.34

1.4

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

442

0.68

1.34

2.3

31.1

25.6

mg/l

0.20

100

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

1.34

0.0

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

247

0.57

1.34

1.1

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.00

1.33

0.0

1.0

—

14.5

—

(3038026) Centromere Ab [Units/volume] in Serum

246

0.57

1.32

1.1

—

56.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

308

0.61

1.32

1.2

1.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

0.00

1.31

0.0

2.3

—

45.8

—

(44806071)

2.50

1.30

1.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

164

1396

1.18

1.29

1.3

155.4

220.0

u/ml

1.00

150

1271

(3026480) Teichoate Ab [Titer] in Serum

2.36

1.29

1.3

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

269

0.59

1.29

1.6

3.2

7.9

32.4

mg/l

—

210

(4024509)

329

0.64

1.27

2.1

1.6

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

292

0.61

1.26

1.5

2.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

482

0.70

1.25

1.1

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.40

1.24

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.40

1.24

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.40

1.24

1.0

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

410

0.68

1.23

1.2

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

323

1.37

1.19

1.3

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

171

0.53

1.17

1.2

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

171

0.53

1.17

1.2

1.3

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

2.00

1.16

1.2

196.2

687.0

u/l

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

1.16

0.0

1.8

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

0.00

1.16

0.0

2.3

—

0.6

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

223

0.58

1.15

1.1

—

3.7

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.50

1.15

1.0

1.4

—

(40758292) HTLV I+II Ab panel - Serum

0.00

1.15

0.0

1.3

—

(3037121) Protein [Mass/volume] in Urine

1099

0.81

1.15

2.3

3.0

0.3

g/l

0.05

439

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

599

1.26

1.13

1.5

1.8

4.3

4.4

iu/l

0.01

189

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

985

9354

1.07

1.13

2.5

57.7

58.7

u/l

0.25

884

8585

(3010503) CD19 cells [#/volume] in Blood

156

0.51

1.13

1.9

2.0

0.2

0.1

e9/l

—

149

(3035933) Granulocytes/100 leukocytes in Blood

2.00

1.12

1.5

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.90

1.12

1.1

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

342

0.67

1.12

1.0

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

185

1616

1.15

1.09

1.6

1.8

1.2

1.5

g/l

0.68

168

1454

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

436

1.29

1.05

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

123

0.49

1.05

1.5

1.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

191

0.57

1.04

9.1

3.8

—

(3040151) Glucose [Moles/volume] in Capillary blood

405

0.71

1.02

4.6

7.1

6.9

7.3

mmol/l

0.23

340

(3047189) Immunofixation for 24 hour Urine

163

1.48

1.01

1.3

1.5

—

(3016228) CD19 cells/100 cells in Blood

107

0.47

1.01

2.2

1.9

8.0

7.8

—

102

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

298

0.67

1.00

2.8

2.1

1.0

2.1

u/field

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

137

1179

1.17

1.00

2.9

2.7

—

(40768806) Pleura Pathology biopsy report

422

1.28

1.00

1.8

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

214

1.41

0.99

1.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

476

1.27

0.99

1.4

1.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.18

0.98

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

242

1.37

0.94

1.2

1.4

564.0

245.0

titre

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.89

0.94

1.0

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

120

0.50

0.93

1.3

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

120

0.50

0.93

1.3

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

102

0.49

0.89

2.2

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

153

0.59

0.88

1.2

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

153

0.59

0.88

1.2

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

153

0.59

0.88

1.2

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

153

0.59

0.88

1.2

1.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.86

0.87

1.0

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.86

0.87

10.6

14.2

7.3

5.5

mmol/l

—

(3022621) pH of Urine by Test strip

181

2028

0.89

0.85

3.6

3.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

282

1.32

0.85

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

191

0.63

0.84

2.1

1.6

—

71.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

309

1.30

0.84

2.0

1.9

22992.7

1930.1

u/l

—

118

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

301

1.30

0.82

1.2

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.65

0.81

1.2

1.3

—

11.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

904

0.84

0.81

2.5

3.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

445

4161

1.08

0.80

1.3

1.2

11.4

13.2

u/ml

0.19

106

1504

(40768800) Prostate Pathology biopsy report

685

0.81

0.79

1.3

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

383

1.26

0.79

1.5

1.4

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.79

0.0

1.0

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

147

1300

1.14

0.79

1.5

10.9

26.2

u/ml

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

452

0.77

0.79

1.2

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.67

0.78

1.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.78

0.0

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.78

0.0

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.78

0.0

3.5

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.78

0.0

1.5

—

(40765096) Chromosome analysis panel by Banding

0.50

0.77

1.2

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

125

0.56

0.77

1.0

1.5

8.4

9.2

ug/l

—

103

(3034860) Kappa light chains.free [Mass/volume] in Serum

135

1190

1.14

0.76

2.4

3.2

43.7

110.8

mg/l

0.80

117

976

(3024263) Appearance of Synovial fluid

174

1.38

0.76

1.3

1.6

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

245

0.69

0.76

1.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

0.76

0.0

1.6

—

0.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

0.76

0.0

1.2

—

12.9

—

(3008295) Osmolality of Serum or Plasma

323

1.27

0.76

1.1

1.3

286.3

275.7

mosm/kgh2o

0.94

242

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

734

1.18

0.75

1.5

1.9

12.7

12.5

mg/l

0.09

670

(3051593) INR in Capillary blood by Coagulation assay

185

0.65

0.75

7.6

17.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.60

0.74

1.7

1.5

—

2284600.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

960

0.85

0.74

7.1

4.3

—

(3019060) Gas panel - Arterial blood

245

2241

1.10

0.74

4.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

167

1.38

0.73

1.5

1.3

0.3

1.5

u/ml

1.14

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

136

0.59

0.72

2.1

1.7

—

(3024869) Neuronal Ab [Presence] in Serum

1.58

0.71

1.0

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

282

1.28

0.71

1.4

1.3

16.1

12.1

u/l

0.51

258

(3024980) IgG subclass 4 [Mass/volume] in Serum

381

1.24

0.70

1.7

1.5

0.8

0.9

g/l

0.16

285

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

160

1.38

0.70

2.1

1.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

974

10101

0.95

0.69

3.7

4.0

8.0

9.2

mg/mmol

0.41

585

6341

(3013005) Retinol [Moles/volume] in Serum or Plasma

1.56

0.68

1.4

2.1

2.0

umol/l

0.42

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.60

0.68

1.5

2.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

296

0.74

0.68

1.2

1.3

477943.6

128218.8

e6/l

0.68

201

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

838

1.15

0.65

1.3

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

133

1187

1.13

0.65

2.5

3.2

48.8

64.4

mg/l

0.33

115

977

(3001019) Free T4 and TSH panel - Serum or Plasma

711

0.84

0.65

2.0

1.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.52

0.62

1.0

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

105

0.57

0.61

3.2

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

105

0.57

0.61

3.2

2.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

105

0.57

0.61

1.2

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

706

0.85

0.61

1.2

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

152

0.66

0.61

1.7

1.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

139

1.37

0.60

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

139

1.37

0.60

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.60

0.0

1.0

—

30.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.50

0.59

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.53

0.59

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.58

0.0

1.1

—

(3017732) Neutrophils [#/volume] in Blood

171

1871

0.91

0.58

3.4

3.3

3.9

4.2

e9/l

0.50

143

1363

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

231

0.73

0.58

1.2

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

726

1.15

0.57

1.2

13.3

45.3

u/ml

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

159

1448

1.10

0.57

1.2

109.2

135.6

iu/ml

0.41

519

(3020779) Urea [Moles/volume] in Serum or Plasma

316

2964

1.07

0.57

5.3

6.6

10.1

11.1

mmol/l

1.74

292

2803

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

129

1162

1.11

0.56

1.6

1.8

40.0

38.8

u/l

0.27

104

987

(3004451) EKG impression Narrative

184

0.71

0.56

1.5

1.3

—

(3045716) Anion gap in Serum or Plasma

172

0.70

0.56

1.6

2.2

9.4

9.1

mmol/l

—

139

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

275

1.24

0.55

1.3

1.1

0.3

1.7

u/ml

2.08

104

(3003888) Timothy IgE Ab [Units/volume] in Serum

239

1.26

0.55

1.1

1.8

4.7

u/ml

1.45

104

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

228

0.74

0.54

1.2

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

321

3020

1.07

0.54

1.9

2.5

70.5

70.0

e9/l

0.05

173

2298

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

215

1.26

0.50

2.9

5.2

274.6

40.5

u/ml

—

(40757373) Influenza virus identified in Isolate

1.47

0.50

1.4

1.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1183

12132

0.96

0.50

4.1

39.3

91.7

ng/l

0.87

719

9242

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.46

0.50

2.0

1.5

48.0

43.2

umol/l

—

(3006462) Nitrate [Presence] in Urine

156

0.70

0.49

3.7

4.1

—

(3014271) Vancomycin [Susceptibility]

190

0.74

0.49

2.4

3.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

653

1.14

0.48

1.7

1.8

—

(4094501)

738

1.13

0.48

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.49

0.47

5.7

8.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1.46

0.46

3.1

9.4

6.8

mg/l

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

154

1668

0.92

0.45

4.1

3.3

25.8

25.2

mmol/l

1.83

148

1620

(4211845)

164

0.73

0.45

3.9

—

(3032773) Endomysium IgG Ab [Titer] in Serum

192

1.25

0.44

1.0

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

1004

9784

1.04

0.43

3.5

3.1

7.1

7.0

mmol/l

0.13

843

8059

(3014599) Egg white IgE Ab [Units/volume] in Serum

1.41

0.43

1.2

1.1

0.2

0.4

u/ml

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

575

0.87

0.43

1.3

1.4

—

(3000330) Specific gravity of Urine by Test strip

161

1734

0.93

0.42

5.1

3.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.40

0.42

1.1

1.6

—

(3052592) Norovirus Ag [Presence] in Stool

1.40

0.42

1.1

1.4

—

(3017704) Immunofixation for Urine

194

1.24

0.42

1.6

1.5

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.43

0.41

1.2

1.9

1.6

mmol/l

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.38

0.41

34.0

8.9

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

150

0.73

0.41

2.5

2.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.52

0.41

1.0

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.41

0.0

2.7

—

(3002256) Pathology report gross observation

410

3927

1.05

0.41

1.4

1.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

107

977

1.10

0.40

1.2

0.2

1.3

u/ml

—

(40758358) Immune stain study

0.00

0.40

0.0

1.0

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.3

—

4.7

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.40

0.0

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.40

0.0

1.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

103

0.68

0.39

19.4

27.0

108.1

118.2

ug/l

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

549

0.87

0.39

1.1

1.5

0.8

nmol/l

0.09

445

(3045683) HLA typing for celiac disease panel - Blood or Tissue

106

0.66

0.39

1.1

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

106

0.66

0.39

1.3

—

(3006270) Folate [Moles/volume] in Blood

251

1.20

0.39

1.2

361.0

347.9

nmol/l

0.12

202

(40768441) Liver Pathology biopsy report

196

1.23

0.39

1.6

1.2

—

(3006245) CD3-CD19+ cells/100 cells in Blood

1.38

0.38

1.2

2.1

11.7

8.7

1.23

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.39

0.38

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

234

1.20

0.37

1.1

0.4

1.4

u/ml

1.03

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.35

0.37

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

202

0.79

0.36

1.1

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.29

0.36

30.7

8.4

—

(3011412) CD3 cells [#/volume] in Blood

234

0.81

0.35

1.5

2.0

1.0

1.1

e9/l

0.18

142

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

0.64

0.35

2.0

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1.43

0.35

2.8

2.9

—

47.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

190

0.79

0.35

1.7

1.9

—

42.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.40

0.35

1.5

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

348

1.15

0.34

1.1

1.5

g/l

0.47

309

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

1.34

0.34

1.2

2.1

24.9

28.7

0.92

(3035880) pH of Pleural fluid

210

1.19

0.32

1.2

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

154

0.78

0.32

1.0

0.0

0.6

u/ml

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

128

1.25

0.32

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

348

0.86

0.31

1.2

1.3

—

nmol/l

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

211

1.19

0.31

1.2

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

609

1.10

0.30

1.5

—

(3003694) ABO and Rh group [Type] in Blood

692

7094

0.97

0.30

1.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.27

0.30

1.0

1.1

—

(3023419) Bacteria identified in Sputum by Culture

448

1.12

0.29

3.0

2.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

367

0.87

0.29

1.5

65.5

63.0

0.13

236

(3009871) Measles virus Ab [Titer] in Serum

1.25

0.29

1.4

1.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.29

0.28

1.3

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

194

0.82

0.27

1.1

1.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1077

10587

1.03

0.27

2.7

3.2

1748.8

1740.9

ng/l

0.02

909

9254

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

116

0.78

0.27

2.4

2.7

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

131

1390

0.94

0.27

3.2

3.8

69.8

83.5

u/ml

0.21

120

1331

(3022145) Colonoscopy Study observation

306

3175

0.96

0.27

1.3

—

(3025941) Bacteria identified in Stool by Culture

149

1411

1.06

0.26

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.19

0.26

1.6

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

214

0.84

0.26

1.8

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.68

0.26

1.0

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

872

0.93

0.25

1.4

1.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.25

0.25

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

675

1.08

0.25

1.2

3.5

3.2

u/ml

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

266

0.86

0.24

1.4

23.5

26.5

0.26

164

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

105

1.24

0.24

1.8

1.9

9.0

nmol/l

0.97

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

329

0.88

0.24

1.7

1.6

—

(3003129) Base excess in Capillary blood by calculation

0.71

0.24

1.0

2.0

0.5

1.2

mmol/l

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

201

0.85

0.23

2.2

2.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

370

1.11

0.23

1.5

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

237

1.14

0.23

1.2

1.4

2.7

2.9

g/l

0.26

163

(3027135) IgG subclass 1 [Mass/volume] in Serum

237

1.14

0.23

1.2

1.4

6.9

7.1

g/l

0.03

164

(3024139) IgG subclass 3 [Mass/volume] in Serum

237

1.14

0.23

1.2

1.4

0.6

0.4

g/l

0.28

163

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.28

0.23

1.4

1.5

86.5

48.3

pmol/l

—

(3008037) Lactate [Moles/volume] in Venous blood

815

0.93

0.22

4.4

3.3

1.6

1.7

mmol/l

0.20

798

(3011985) Renin [Units/volume] in Plasma

371

1.11

0.22

1.8

1.3

99.8

58.4

mu/l

0.31

323

(40768446) Kidney Pathology biopsy report

0.76

0.22

1.0

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

219

1.14

0.22

1.7

2.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

163

1.17

0.21

1.7

1.6

7.3

7.1

umol/l

0.02

101

(3013466) aPTT in Blood by Coagulation assay

0.00

0.21

0.0

1.0

—

38.9

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.3

—

4.1

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.21

0.0

1.1

—

0.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

7.7

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.21

0.0

1.9

—

4.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

459

1.09

0.21

1.6

1.3

5.9

10.6

u/l

4.27

365

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(4062490)

239

1.13

0.21

1.2

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

469

1.09

0.21

2.8

2.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

134

0.82

0.20

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

155

0.84

0.20

1.1

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

154

0.84

0.19

1.2

1.1

85.5

83.5

u/l

—

117

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.13

0.18

1.0

1.6

94.3

130.8

ng/l

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

156

1.15

0.18

3.9

6.6

—

(1175426) CD3 cells/100 lymphocytes in Blood

185

0.86

0.18

1.5

2.0

71.1

71.7

0.06

171

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

242

1.12

0.18

1.1

1.2

—

(3024932) HLA-DR beta [Type]

1.19

0.18

1.1

—

(3024471) HLA-A [Type]

1.17

0.17

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.15

0.17

2.1

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

224

1.12

0.17

1.2

—

(3020650) Glucose [Presence] in Urine

0.71

0.16

1.4

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.18

0.16

1.0

1.1

1614.5

1607.7

miu/ml

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

235

0.89

0.16

1.8

1.5

—

(3041354) Potassium [Moles/volume] in Venous blood

477

1.07

0.15

2.8

2.4

4.0

4.1

mmol/l

1.35

472

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.14

0.15

1.2

1.5

9.0

9.3

ug/l

—

(3028433) Virus identified in Specimen by Culture

1.18

0.14

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

112

1.16

0.14

1.7

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

367

3600

1.02

0.14

3.1

4.0

4.5

21.8

ug/l

5.57

276

2989

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

103

1.17

0.13

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

247

1.09

0.13

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

247

1.09

0.13

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

383

1.07

0.13

1.8

2.1

10.4

1170.2

u/ml

0.89

372

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

686

1.05

0.13

1.2

4.6

7.1

u/ml

0.46

118

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

325

0.92

0.13

1.0

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

180

0.89

0.13

1.5

2.0

18.3

15.7

0.27

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

107

0.84

0.13

1.0

—

(3044927) Protein electrophoresis panel - Urine

365

0.93

0.12

1.3

1.2

—

(3008898) HLA-B27 [Presence]

620

1.05

0.12

1.0

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

915

0.96

0.12

1.6

1.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

292

0.92

0.11

1.4

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

157

0.89

0.11

1.1

1.2

—

(3012516) Albumin [Mass/volume] in Urine

949

9572

0.99

0.11

3.1

3.2

396.7

282.4

mg/l

0.32

580

6055

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

504

1.05

0.11

2.4

3.9

29.5

38.2

u/ml

0.40

494

(3006184) Hemoglobin [Mass/volume] in Capillary blood

801

0.96

0.11

2.1

2.3

127.0

126.4

g/l

0.06

585

(3014148) Varicella zoster virus Ab [Titer] in Serum

198

0.91

0.10

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

177

0.90

0.10

1.8

1.5

—

(44806420)

125

1.12

0.10

2.6

2.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

399

1.05

0.09

1.3

0.7

nmol/l

0.09

377

(3042733) HLA Ab [Presence] in Serum

1.11

0.09

3.3

4.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.83

0.08

2.2

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.08

0.08

1.3

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.04

0.08

1.4

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

0.83

0.07

2.3

1.8

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

112

0.89

0.07

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

328

3319

0.99

0.07

3.3

3.7

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

580

1.04

0.07

1.2

—

0.6

—

(3038515) Glucose [Moles/volume] in Venous blood

772

0.97

0.07

4.4

3.4

7.1

7.7

mmol/l

1.55

756

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.06

0.07

1.3

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.06

0.07

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

344

1.05

0.06

1.3

338.2

275.9

pmol/l

0.71

262

(3011648) Oxygen content in Venous blood

236

1.06

0.06

1.5

1.7

11.4

10.5

0.42

236

(3014051) Protein [Presence] in Urine by Test strip

710

1.03

0.06

2.4

2.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

103

0.87

0.06

1.4

1.8

28.7

63.1

u/l

—

(3035637) Corticotropin [Mass/volume] in Plasma

325

1.05

0.06

1.8

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

162

0.93

0.06

1.0

1.1

6.7

4.5

u/ml

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

286

1.05

0.06

1.1

1.3

5.9

7.9

mmol/l

4.85

198

(3020961) Endomysium IgA Ab [Titer] in Serum

105

1031

1.02

0.05

1.1

225.0

174.4

titre

—

(3037756) Immunofixation for Serum or Plasma

783

1.02

0.05

1.7

1.5

—

(4281824)

318

1.04

0.04

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

372

0.97

0.04

1.6

1.9

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

180

0.94

0.04

2.3

2.2

16.2

119.2

ug/min

—

(3005570) Glucose [Moles/volume] in Urine

301

0.96

0.03

2.0

—

(3005033) Fetal Nuchal fold Thickness US

129

0.93

0.03

1.7

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

208

2099

0.99

0.03

6.6

7.0

24.7

24.6

mmol/l

0.17

195

1952

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

400

1.03

0.02

1.3

0.1

0.3

nmol/l

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

158

0.95

0.02

1.9

2.5

41.1

37.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

178

0.95

0.02

1.0

1.2

2.1

u/ml

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

800

0.99

0.02

1.6

1.7

—

(44790048)

327

0.98

0.01

1.3

1.4

—

(44806118)

327

0.98

0.01

1.3

1.4

—

(44790049)

327

0.98

0.01

1.3

1.4

—

(44790047)

327

0.98

0.01

1.3

1.4

—

(3045142) Bone marrow Pathology biopsy report

377

0.98

0.01

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

176

0.97

0.00

1.5

2.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

204

1.03

0.00

1.1

1.5

3.1

u/ml

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

318

3173

1.00

0.00

1.4

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

132

0.98

0.00

1.1

1.3

95.8

68.0

pmol/l

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

162

0.99

0.00

1.6

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

162

0.99

0.00

1.6

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

162

0.99

0.00

1.6

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

162

0.99

0.00

1.6

1.4

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

105

0.95

0.00

1.4

1.1

268.3

249.0

iu/ml

—

105

(21494434) Karyotype in Bone marrow

312

0.99

0.00

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

562

1.00

0.00

1.2

24.4

48.2

u/l

1.60

490

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

758

1.00

0.00

1.6

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

129

1.01

0.00

1.6

1.4

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

151

0.99

0.00

1.3

1.2

171.7

363.7

u/l

1.28

138

(44813793)

159

1.01

0.00

1.1

1.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

231

1.00

0.00

1.0

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

369

1.00

0.00

1.2

1.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

152

1517

1.00

0.00

2.5

2.4

0.6

0.7

0.16

147

1444

(3043238) Trisomy 21 risk [Likelihood] in Fetus

133

0.98

0.00

1.7

1.5

—

(3013762) Body weight Measured

0.00

0.0

1.6

—

(3002619) Bacteria identified in Specimen by Culture

0.98

0.00

1.0

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3000285) Sodium [Moles/volume] in Blood

0.98

0.00

1.0

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.4

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.1

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.0

1.1

—

0.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3022229) Phosphate [Moles/volume] in Urine

0.00

0.0

1.0

—

20.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.97

0.00

1.4

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.0

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

1.01

0.00

1.7

1.3

2.8

3.5

umol/l

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

130

1.00

0.00

1.1

1.2

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

8.0

—

32.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.00

0.00

1.0

1.3

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

1.9

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.0

—

391.8

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

750

1.00

0.00

1.4

1.6

0.0

0.2

iu/ml

2.30

158

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.88

0.00

1.4

1.7

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.01

0.00

1.0

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

3.0

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.0

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint MEMLOSS and mortality.

Females

Parameter	HR [95% CI]	p-value
MEMLOSS	1.425 [1.29, 1.57]	< 0.001
Birth year	0.998 [0.99, 1.01]	0.601

During the follow-up period (1.1.1998 — 31.12.2019), 4259 out of 13459 females with MEMLOSS died.

Males

Parameter	HR [95% CI]	p-value
MEMLOSS	1.542 [1.38, 1.72]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 3776 out of 10590 males with MEMLOSS died.

Mortality risk

Mortality risk for people of age

years, who have MEMLOSS.

N-year risk	Females	Males
1	0.157%	0.285%
5	0.858%	1.859%
10	2.264%	4.693%
15	4.217%	8.456%
20	7.286%	13.969%

Relationships between endpoints

↥

Index endpoint: MEMLOSS – Memory loss

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Memory loss

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints